<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antiviral Agents Herpes Hiv Influenza Hbv And Hcv - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">17</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x261c82=_0x4c18;(function(_0x39b5aa,_0x10aca8){const _0xc1d664=_0x4c18,_0x5d6c0d=_0x39b5aa();while(!![]){try{const _0x412a63=-parseInt(_0xc1d664(0x2dc))/0x1*(parseInt(_0xc1d664(0x2a0))/0x2)+parseInt(_0xc1d664(0x40e))/0x3+-parseInt(_0xc1d664(0x2b0))/0x4+-parseInt(_0xc1d664(0x3a0))/0x5*(-parseInt(_0xc1d664(0x253))/0x6)+parseInt(_0xc1d664(0x284))/0x7*(parseInt(_0xc1d664(0x1f3))/0x8)+parseInt(_0xc1d664(0x3e0))/0x9*(-parseInt(_0xc1d664(0x322))/0xa)+parseInt(_0xc1d664(0x396))/0xb;if(_0x412a63===_0x10aca8)break;else _0x5d6c0d['push'](_0x5d6c0d['shift']());}catch(_0xb63034){_0x5d6c0d['push'](_0x5d6c0d['shift']());}}}(_0x1a28,0xc1119));const _0x181859=(function(){const _0x5a92bf=_0x4c18,_0x4b9676={'pxlaj':_0x5a92bf(0x27a),'OjhSB':function(_0x137a28){return _0x137a28();},'XnjsM':function(_0x427c14,_0x56cb1e){return _0x427c14!==_0x56cb1e;},'BtcNk':_0x5a92bf(0x1d1)};let _0x252bde=!![];return function(_0xed1058,_0x5c655b){const _0x3f358a=_0x252bde?function(){const _0x2a5c82=_0x4c18,_0x52d941={'HTvOK':_0x2a5c82(0x364),'EVnQE':_0x4b9676[_0x2a5c82(0x1c5)],'wAEgd':function(_0x3a19d3){const _0x3ff2d6=_0x2a5c82;return _0x4b9676[_0x3ff2d6(0x2f8)](_0x3a19d3);}};if(_0x5c655b){if(_0x4b9676[_0x2a5c82(0x3ad)](_0x4b9676[_0x2a5c82(0x294)],_0x2a5c82(0x1d1)))_0x3e90f4=_0x468297,_0x2027e6[_0x2a5c82(0x37d)](_0x52d941['HTvOK'])[_0x2a5c82(0x380)][_0x2a5c82(0x2df)]=_0x52d941[_0x2a5c82(0x1dc)],_0x52d941[_0x2a5c82(0x3a2)](_0x189e7e);else{const _0x21e8c4=_0x5c655b[_0x2a5c82(0x407)](_0xed1058,arguments);return _0x5c655b=null,_0x21e8c4;}}}:function(){};return _0x252bde=![],_0x3f358a;};}()),_0x223e95=_0x181859(this,function(){const _0xf1fdfd=_0x4c18,_0x1c127a={'DaqOF':_0xf1fdfd(0x228)};return _0x223e95[_0xf1fdfd(0x265)]()[_0xf1fdfd(0x290)](_0x1c127a['DaqOF'])['toString']()[_0xf1fdfd(0x449)](_0x223e95)[_0xf1fdfd(0x290)](_0x1c127a['DaqOF']);});_0x223e95();const _0xa78927=(function(){const _0x182012={'ISCFW':function(_0x1e04ec,_0x17384d){return _0x1e04ec-_0x17384d;},'ndvxC':function(_0x292ba3){return _0x292ba3();},'BEzAD':function(_0xa70b79,_0xbc0a7b){return _0xa70b79!==_0xbc0a7b;},'RwqWR':'ygpoK','qHOiM':'evLlc'};let _0x4985a2=!![];return function(_0x21b1b8,_0x27d208){const _0xacc9af=_0x4c18,_0x4b7e34={'nBOWM':function(_0x29d273,_0x50c587){return _0x182012['ISCFW'](_0x29d273,_0x50c587);},'JteWx':function(_0x584160){return _0x182012['ndvxC'](_0x584160);},'kqbjs':function(_0xc2670c,_0x1acf8c){const _0x3698d5=_0x4c18;return _0x182012[_0x3698d5(0x387)](_0xc2670c,_0x1acf8c);},'boTje':_0x182012[_0xacc9af(0x2f9)],'goBwU':_0x182012[_0xacc9af(0x1e0)]},_0x504a17=_0x4985a2?function(){const _0x2cabdb=_0xacc9af,_0x376952={'xlxYe':function(_0x25da43,_0x3785a7){const _0x3ad154=_0x4c18;return _0x4b7e34[_0x3ad154(0x2e3)](_0x25da43,_0x3785a7);},'RMqpa':function(_0xf70b30){return _0x4b7e34['JteWx'](_0xf70b30);}};if(_0x27d208){if(_0x4b7e34[_0x2cabdb(0x3ab)](_0x4b7e34[_0x2cabdb(0x37c)],_0x4b7e34[_0x2cabdb(0x277)])){const _0x14e772=_0x27d208['apply'](_0x21b1b8,arguments);return _0x27d208=null,_0x14e772;}else _0x122712&&(_0x29f0ca[_0x4fb808][_0x2cabdb(0x416)]+=_0x376952[_0x2cabdb(0x413)](_0x74559['now'](),_0x2c81a2)),_0x4a7b2b=_0xb0d691,_0x376952[_0x2cabdb(0x48f)](_0xe686f4),_0x16c1bd();}}:function(){};return _0x4985a2=![],_0x504a17;};}()),_0x330236=_0xa78927(this,function(){const _0x41f350=_0x4c18,_0x191238={'BwTPK':function(_0xf70c60,_0x31181c){return _0xf70c60(_0x31181c);},'OiMAh':function(_0x14b27b,_0x116a82){return _0x14b27b+_0x116a82;},'lFdBl':'return\x20(function()\x20','TlwWa':function(_0x5f088f){return _0x5f088f();},'fSTUM':'log','KmJMo':_0x41f350(0x391),'HNuak':'info','vbOHL':'error','QQTIL':'exception','CgMyF':_0x41f350(0x358),'VVEhp':function(_0x5e2c42,_0xb7b03f){return _0x5e2c42<_0xb7b03f;}};let _0x3af9ed;try{const _0x19a9a1=_0x191238[_0x41f350(0x1e2)](Function,_0x191238[_0x41f350(0x1be)](_0x191238['OiMAh'](_0x191238[_0x41f350(0x40d)],_0x41f350(0x460)),');'));_0x3af9ed=_0x191238[_0x41f350(0x22f)](_0x19a9a1);}catch(_0x32f311){_0x3af9ed=window;}const _0x1cfa58=_0x3af9ed[_0x41f350(0x1d6)]=_0x3af9ed[_0x41f350(0x1d6)]||{},_0x5ac97f=[_0x191238[_0x41f350(0x237)],_0x191238[_0x41f350(0x33f)],_0x191238[_0x41f350(0x43c)],_0x191238['vbOHL'],_0x191238['QQTIL'],_0x41f350(0x250),_0x191238[_0x41f350(0x3bc)]];for(let _0x1e318b=0x0;_0x191238['VVEhp'](_0x1e318b,_0x5ac97f['length']);_0x1e318b++){const _0x1a9134=_0xa78927[_0x41f350(0x449)][_0x41f350(0x46f)][_0x41f350(0x39d)](_0xa78927),_0x44d395=_0x5ac97f[_0x1e318b],_0x5c5792=_0x1cfa58[_0x44d395]||_0x1a9134;_0x1a9134[_0x41f350(0x2f2)]=_0xa78927[_0x41f350(0x39d)](_0xa78927),_0x1a9134['toString']=_0x5c5792['toString'][_0x41f350(0x39d)](_0x5c5792),_0x1cfa58[_0x44d395]=_0x1a9134;}});_0x330236();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x261c82(0x23f)},{'id':0x2,'text':_0x261c82(0x36f)},{'id':0x3,'text':_0x261c82(0x225)},{'id':0x4,'text':_0x261c82(0x23d)}],'text':_0x261c82(0x341),'unique_key':_0x261c82(0x409),'question_audio':null,'question_video':null,'map_id':0x11f4e5,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x464),'correct_choice_id':0x2,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':_0x261c82(0x1ff)},{'id':0xc,'text':_0x261c82(0x313)},{'id':0xd,'text':_0x261c82(0x3d6)},{'id':0xe,'text':_0x261c82(0x2c5)}],'text':_0x261c82(0x37a),'unique_key':'DT1176807','question_audio':null,'question_video':null,'map_id':0x11f4e7,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x261c82(0x33a),'correct_choice_id':0xd,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x261c82(0x21b)},{'id':0x16,'text':_0x261c82(0x41a)},{'id':0x17,'text':_0x261c82(0x3cc)},{'id':0x18,'text':_0x261c82(0x344)}],'text':_0x261c82(0x423),'unique_key':_0x261c82(0x3ff),'question_audio':null,'question_video':null,'map_id':0x11f4ec,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x306),'correct_choice_id':0x17,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':_0x261c82(0x220)},{'id':0x20,'text':_0x261c82(0x296)},{'id':0x21,'text':_0x261c82(0x3c5)},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Trifluridine</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2050-year-old\x20man\x20is\x20being\x20treated\x20with\x20IV\x20acyclovir\x20for\x20HSV-1\x20encephalitis,\x20confirmed\x20by\x20CSF\x20culture.\x20He\x20initially\x20improves\x20but\x20develops\x20a\x20fever\x20with\x20chills\x20on\x20day\x2010.\x20Repeat\x20CSF\x20analysis\x20shows\x20HSV-1\x20resistant\x20to\x20acyclovir.\x20Which\x20IV\x20drug\x20is\x20preferred\x20for\x20treating\x20acyclovir-resistant\x20HSV\x20infections?</span></p>','unique_key':'DT1176815','question_audio':null,'question_video':null,'map_id':0x11f4ef,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x261c82(0x379),'correct_choice_id':0x20,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':_0x261c82(0x316)},{'id':0x2a,'text':_0x261c82(0x3ae)},{'id':0x2b,'text':_0x261c82(0x3e7)},{'id':0x2c,'text':_0x261c82(0x2fe)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>In\x20patients\x20with\x20AIDS\x20receiving\x20high-dose\x20chronic\x20valacyclovir\x20therapy\x20(8\x20g/day),\x20which\x20of\x20the\x20following\x20complications\x20has\x20been\x20observed\x20with\x20increased\x20incidence?</span></p>','unique_key':'DT1176819','question_audio':null,'question_video':null,'map_id':0x11f4f3,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li><strong>Valacyclovir</strong>\x20is\x20generally\x20well\x20tolerated,\x20although\x20nausea,\x20headache,\x20vomiting,\x20or\x20rash\x20occasionally\x20occur.</li>\x0a<li>At\x20high\x20doses,\x20confusion,\x20hallucinations,\x20and\x20seizures\x20have\x20been\x20reported.</li>\x0a<li>AIDS\x20patients\x20who\x20received\x20high-dose\x20valacyclovir\x20chronically\x20(ie,\x208\x20g/d)\x20had\x20an\x20increased\x20incidence\x20of\x20gastrointestinal\x20intolerance\x20as\x20well\x20as\x20<strong>thrombotic\x20thrombocytopenic\x20purpura</strong>\x20and<strong>\x20hemolytic-uremic\x20syndrome</strong>;\x20this\x20dose\x20has\x20also\x20been\x20associated\x20with\x20confusion\x20and\x20hallucinations\x20in\x20transplant\x20patients.</li>\x0a<li>In\x20a\x20recent\x20study,\x20there\x20was\x20no\x20evidence\x20of\x20increased\x20birth\x20defects\x20in\x20181\x20infants\x20who\x20were\x20exposed\x20to\x20valacyclovir\x20during\x20the\x20first\x20trimester.</li>\x0a</ul>\x0a<p><strong>Valacyclovir:</strong></p>\x0a<ul>\x0a<li>Valacyclovir\x20is\x20the\x20L-valyl\x20ester\x20prodrug\x20of\x20acyclovir.</li>\x0a<li>After\x20oral\x20administration,\x20it\x20undergoes\x20<strong>first-pass\x20hydrolysis</strong>\x20in\x20the\x20<strong>liver\x20and\x20intestine</strong>,\x20converting\x20rapidly\x20to\x20acyclovir.</li>\x0a<li>This\x20conversion\x20results\x20in\x20<strong>serum\x20levels\x203-5\x20times\x20higher</strong>\x20than\x20oral\x20acyclovir,\x20<strong>approximating\x20IV\x20acyclovir</strong>\x20levels.</li>\x0a</ul>\x0a<p><strong>Clinical\x20Uses:</strong></p>\x0a<ul>\x0a<li>Herpes\x20simplex\x20virus\x20(HSV)\x20infections</li>\x0a<li>Varicella-zoster\x20virus\x20(VZV)\x20infections</li>\x0a<li>Cytomegalovirus\x20(CMV)\x20prophylaxis\x20in\x20certain\x20settings</li>\x0a<li><strong>Suppressive\x20therapy</strong>\x20from\x2036\x20weeks\x20of\x20gestation\x20in\x20<strong>pregnant\x20women</strong>\x20with\x20<strong>recurrent\x20genital\x20herpes</strong></li>\x0a</ul>\x0a<p><strong>Adverse\x20Effects:</strong></p>\x0a<ul>\x0a<li>Common:\x20Nausea,\x20headache,\x20vomiting,\x20rash</li>\x0a<li>High\x20doses\x20(e.g.,\x208\x20g/day):\x0a<ul>\x0a<li><strong>Neurotoxicity</strong>:\x20Confusion,\x20hallucinations,\x20seizures\x20(especially\x20in\x20transplant\x20patients)</li>\x0a<li><strong>AIDS\x20patients</strong>:\x20Increased\x20risk\x20of\x20<strong>thrombotic\x20thrombocytopenic\x20purpura\x20(TTP)/hemolytic\x20uremic\x20syndrome\x20(HUS)</strong>\x20and\x20<strong>GI\x20intolerance</strong></li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong><strong>Explanation\x20of\x20Other\x20Options:</strong></strong></p>\x0a<p><strong>Idiopathic\x20Thrombocytopenic\x20Purpura\x20(Option\x20A):\x20ITP</strong>\x20is\x20an\x20autoimmune\x20condition\x20where\x20the\x20body\x20attacks\x20its\x20platelets,\x20leading\x20to\x20thrombocytopenia.\x20ITP\x20is\x20typically\x20triggered\x20by\x20viral\x20infections,\x20autoimmune\x20diseases,\x20or\x20certain\x20drugs,\x20but\x20<strong>valacyclovir\x20is\x20not\x20among\x20them</strong>.</p>\x0a<p><strong>Colon\x20carcinoma(Option\x20C):\x20</strong>Valacyclovir\x20is\x20<strong>not\x20mutagenic\x20or\x20carcinogenic</strong>,\x20and\x20there\x20is\x20<strong>no\x20evidence</strong>\x20that\x20it\x20increases\x20the\x20risk\x20of\x20any\x20malignancy.</p>','correct_choice_id':0x2a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Acyclovir</span></p>'},{'id':0x34,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Valacyclovir</span></p>'},{'id':0x35,'text':_0x261c82(0x38b)},{'id':0x36,'text':_0x261c82(0x2fe)}],'text':_0x261c82(0x44b),'unique_key':_0x261c82(0x30b),'question_audio':null,'question_video':null,'map_id':0x11f4f6,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x35b),'correct_choice_id':0x36,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x261c82(0x467)},{'id':0x3e,'text':_0x261c82(0x41b)},{'id':0x3f,'text':_0x261c82(0x242)},{'id':0x40,'text':_0x261c82(0x24a)}],'text':_0x261c82(0x303),'unique_key':_0x261c82(0x480),'question_audio':null,'question_video':null,'map_id':0x11f4f8,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x325),'correct_choice_id':0x3f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':_0x261c82(0x2bf)},{'id':0x48,'text':_0x261c82(0x401)},{'id':0x49,'text':_0x261c82(0x3cb)},{'id':0x4a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Fusion\x20inhibitors</span></p>'}],'text':_0x261c82(0x318),'unique_key':_0x261c82(0x2f4),'question_audio':null,'question_video':null,'map_id':0x11f503,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x3d5),'correct_choice_id':0x49,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Abacavir\x20is\x20an\x20NNRTI\x20agent</span></p>'},{'id':0x52,'text':_0x261c82(0x26d)},{'id':0x53,'text':_0x261c82(0x46c)},{'id':0x54,'text':_0x261c82(0x31e)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20true\x20for\x20Abacavir?</span></p>','unique_key':_0x261c82(0x2a6),'question_audio':null,'question_video':null,'map_id':0x11f504,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':'<p><strong>Explanation</strong>:</p>\x0a<p><strong>HLA-B5701\x20testing\x20is\x20mandatory</strong>\x20before\x20starting\x20therapy.\x20If\x20a\x20patient\x20is\x20positive\x20for\x20this\x20allele,\x20<strong>abacavir\x20is\x20contraindicated</strong>.\x20This\x20test\x20is\x20essential\x20to\x20reduce\x20the\x20risk\x20of\x20<strong>abacavir\x20hypersensitivity\x20reaction</strong>,\x20which\x20can\x20be\x20severe\x20and\x20life-threatening.</p>\x0a<p><strong>Abacavir:\x20</strong></p>\x0a<p><strong>Drug\x20Class:</strong></p>\x0a<ul>\x0a<li>Nucleoside\x20Reverse\x20Transcriptase\x20Inhibitor\x20(NRTI)<strong>(Option\x20A\x20ruled\x20out)</strong></li>\x0a<li>Guanosine\x20analog</li>\x0a</ul>\x0a<p><strong>Pharmacokinetics:</strong></p>\x0a<ul>\x0a<li><strong>Oral\x20bioavailability:</strong>\x20~83%\x20(not\x20affected\x20by\x20food)</li>\x0a<li><strong>Half-life\x20(serum):</strong>\x20~1.5\x20hours</li>\x0a<li><strong>Metabolism:</strong>\x0a<ul>\x0a<li>Hepatic:\x20via\x20<strong>glucuronidation</strong>\x20and\x20<strong>carboxylation</strong></li>\x0a<li>Also\x20metabolized\x20by\x20<strong>alcohol\x20dehydrogenase</strong>\x20&rarr;\x20alcohol\x20increases\x20abacavir\x20serum\x20levels</li>\x0a</ul>\x0a</li>\x0a<li><strong>CSF\x20penetration:</strong>\x20~1/3\x20of\x20plasma\x20levels</li>\x0a</ul>\x0a<p><strong>Drug\x20Interactions:</strong></p>\x0a<ul>\x0a<li><strong>Increased\x20levels\x20with\x20alcohol</strong>\x20(ethanol\x20competes\x20for\x20metabolism)<strong>(Option\x20B\x20ruled\x20out)</strong></li>\x0a<li>Decreased\x20levels\x20when\x20co-administered\x20with:\x0a<ul>\x0a<li>Atazanavir</li>\x0a<li>Lopinavir</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Adverse\x20Effects:</strong></p>\x0a<h4><strong>Hypersensitivity\x20Reaction\x20(HSR):</strong></h4>\x0a<ul>\x0a<li>Seen\x20in\x20<strong>~8%</strong>\x20of\x20patients</li>\x0a<li>May\x20be\x20<strong>fatal</strong></li>\x0a<li>More\x20severe\x20with\x20<strong>once-daily\x20dosing</strong></li>\x0a<li><strong>Onset:</strong>\x20Usually\x20within\x20the\x20<strong>first\x206\x20weeks</strong></li>\x0a<li><strong>Symptoms:</strong>\x0a<ul>\x0a<li>Fever,\x20fatigue,\x20nausea,\x20vomiting,\x20diarrhea</li>\x0a<li>Abdominal\x20pain,\x20rash\x20(~50%),\x20dyspnea,\x20cough</li>\x0a<li>Elevated\x20<strong>ALT,\x20CK</strong>\x20levels</li>\x0a</ul>\x0a</li>\x0a<li><strong>Management:</strong>\x0a<ul>\x0a<li><strong>Do\x20not\x20rechallenge</strong></li>\x0a<li><strong>HLA-B*5701\x20testing\x20is\x20mandatory</strong>\x20before\x20starting\x20therapy\x0a<ul>\x0a<li>Positive\x20predictive\x20value:\x20~50%</li>\x0a<li><strong>Negative\x20predictive\x20value:\x20~100%</strong></li>\x0a</ul>\x0a</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Other\x20Adverse\x20Effects:</strong></p>\x0a<ul>\x0a<li>Rash\x20(~5%)</li>\x0a<li>Headache,\x20fatigue,\x20dyspnea</li>\x0a<li><strong>Pancreatitis</strong>\x20(less\x20common)</li>\x0a<li><strong>Potential\x20CV\x20risk:</strong>\x20Avoid\x20in\x20patients\x20with\x20<strong>coronary\x20artery\x20disease</strong></li>\x0a<li><strong>Mitochondrial\x20toxicity\x20&amp;\x20lipid\x20disorders:</strong>\x20Less\x20common\x20than\x20with\x20other\x20NRTIs</li>\x0a</ul>\x0a<p><strong>Use\x20in\x20Pregnancy:\x20Recommended</strong>\x20for\x20use\x20in\x20pregnant\x20women\x20as\x20part\x20of\x20a\x20combination\x20ART</p>','correct_choice_id':0x53,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x261c82(0x26b)},{'id':0x5c,'text':_0x261c82(0x384)},{'id':0x5d,'text':_0x261c82(0x3ea)},{'id':0x5e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Abacavir\x20+\x20Lamivudine\x20+\x20Rilpivirine</span></p>'}],'text':_0x261c82(0x3c9),'unique_key':'DT1176838','question_audio':null,'question_video':null,'map_id':0x11f506,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x261c82(0x49a),'correct_choice_id':0x5d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':_0x261c82(0x2b7)},{'id':0x66,'text':_0x261c82(0x397)},{'id':0x67,'text':_0x261c82(0x441)},{'id':0x68,'text':_0x261c82(0x37f)}],'text':_0x261c82(0x1f7),'unique_key':_0x261c82(0x3e6),'question_audio':null,'question_video':null,'map_id':0x11f507,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x3a8),'correct_choice_id':0x68,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x261c82(0x211)},{'id':0x70,'text':_0x261c82(0x430)},{'id':0x71,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Tenofovir</span></p>'},{'id':0x72,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Sofosbuvir</span></p>'}],'text':_0x261c82(0x398),'unique_key':_0x261c82(0x1e9),'question_audio':null,'question_video':null,'map_id':0x11f509,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x479),'correct_choice_id':0x6f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':_0x261c82(0x1ce)},{'id':0x7a,'text':_0x261c82(0x1e8)},{'id':0x7b,'text':_0x261c82(0x234)},{'id':0x7c,'text':_0x261c82(0x496)}],'text':_0x261c82(0x466),'unique_key':_0x261c82(0x2b1),'question_audio':null,'question_video':null,'map_id':0x11f50a,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x31c),'correct_choice_id':0x7b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':_0x261c82(0x3b9)},{'id':0x84,'text':_0x261c82(0x319)},{'id':0x85,'text':_0x261c82(0x23c)},{'id':0x86,'text':_0x261c82(0x29c)}],'text':_0x261c82(0x1d0),'unique_key':_0x261c82(0x209),'question_audio':null,'question_video':null,'map_id':0x11f50b,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x3b3),'correct_choice_id':0x86,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x261c82(0x3e8)},{'id':0x8e,'text':_0x261c82(0x441)},{'id':0x8f,'text':_0x261c82(0x2b7)},{'id':0x90,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Zidovudine</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20not\x20approved\x20for\x20HBV\x20treatment?</span></p>','unique_key':'DT1176845','question_audio':null,'question_video':null,'map_id':0x11f50d,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x1f4),'correct_choice_id':0x90,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x261c82(0x2b7)},{'id':0x98,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Zidovudine</span></p>'},{'id':0x99,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Sofosbuvir</span></p>'},{'id':0x9a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20of\x20the\x20above</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20drug\x20is\x20useful\x20against\x20HCV?</span></p>','unique_key':_0x261c82(0x439),'question_audio':null,'question_video':null,'map_id':0x11f510,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p><strong>Sofosbuvir(\x20Nucleotide\x20Analog\x20for\x20HCV):</strong></p>\x0a<p><strong>Mechanism\x20of\x20Action:\x20</strong></p>\x0a<ul>\x0a<li><strong>Prodrug</strong>\x20converted\x20intracellularly\x20to\x20active\x20<strong>uridine\x20analog\x20triphosphate</strong>\x20(GS-461203).</li>\x0a<li>Incorporated\x20into\x20viral\x20RNA\x20by\x20<strong>NS5B\x20RNA-dependent\x20RNA\x20polymerase</strong>.</li>\x0a<li>Causes\x20<strong>chain\x20termination</strong>,\x20halting\x20HCV\x20replication.</li>\x0a</ul>\x0a<p><strong>Indications\x20&amp;\x20Combinations</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905a4e38394-d7dc-457c-9140-3aef5d9208d9.png\x22>\x0a<p><strong>Pharmacokinetics</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905295e8ff8-70f3-4c2b-8b16-0b8ba3958488.png\x22>\x0a<p><strong>Adverse\x20Effects</strong></p>\x0a<ul>\x0a<li><strong>Common</strong>\x20(in\x20combination\x20therapy):\x20Fatigue,\x20headache,\x20asthenia</li>\x0a<li><strong>Rare\x20but\x20notable</strong>:\x20<strong>Symptomatic\x20bradycardia</strong>\x20(especially\x20with\x20<strong>amiodarone</strong>,\x20&beta;-blockers,\x20or\x20advanced\x20liver\x20disease),\x20<strong>Severe\x20cutaneous\x20reactions</strong></li>\x0a</ul>\x0a<p><strong><strong>Treatment\x20of\x20Hepatitis\x20C:</strong></strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090530520de8-6071-4c24-89a3-e78a199a787f.png\x22>\x0a<p><strong>DAAs\x20target\x20proteins\x20essential\x20for\x20viral\x20replication:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090589a42f81-7e9e-43bf-9d1a-fb8fa5de3b33.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Tenofovir(Option\x20A):\x20</strong>Tenofovir\x20is\x20a\x20nucleotide\x20reverse\x20transcriptase\x20inhibitor\x20(NRTI)\x20primarily\x20used\x20for\x20HIV\x20and\x20HBV\x20infections.\x20It\x20has\x20no\x20significant\x20role\x20in\x20treating\x20HCV.\x20While\x20some\x20studies\x20explored\x20its\x20use\x20in\x20coinfection\x20settings,\x20Tenofovir\x20does\x20not\x20directly\x20act\x20on\x20the\x20HCV\x20replication\x20machinery.</p>\x0a<p><strong>Zidovudine(Option\x20B):</strong>\x20Zidovudine\x20is\x20also\x20an\x20NRTI\x20used\x20in\x20the\x20management\x20of\x20HIV.\x20It\x20has\x20no\x20antiviral\x20activity\x20against\x20HCV\x20and\x20is\x20not\x20part\x20of\x20any\x20HCV\x20treatment\x20regimen.</p>','correct_choice_id':0x99,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x261c82(0x2d8),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':_0x261c82(0x31b)},{'id':0xa2,'text':_0x261c82(0x3fc)},{'id':0xa3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Remdesivir</span></p>'},{'id':0xa4,'text':_0x261c82(0x2fe)}],'text':_0x261c82(0x3e3),'unique_key':_0x261c82(0x382),'question_audio':null,'question_video':null,'map_id':0x11f511,'difficulty_level':_0x261c82(0x377),'subjects_id':[0x1],'solution':_0x261c82(0x262),'correct_choice_id':0xa1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x261c82(0x24d)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x261c82(0x35d);const quizFilename='antiviral-agents-herpes-hiv-influenza-hbv-and-hcv-a8747882.html';let hierarchy=[_0x261c82(0x268),_0x261c82(0x2e5),'Pharmacology'];if(window[_0x261c82(0x361)][_0x261c82(0x2b5)][_0x261c82(0x40a)](_0x261c82(0x21d))){const customData=JSON[_0x261c82(0x374)](localStorage['getItem'](_0x261c82(0x26c)));if(customData){const irmjad=_0x261c82(0x447)[_0x261c82(0x3f5)]('|');let tQoUei=0x0;while(!![]){switch(irmjad[tQoUei++]){case'0':hierarchy=customData[_0x261c82(0x3f6)];continue;case'1':quizName=customData['name'];continue;case'2':document[_0x261c82(0x468)]=quizName+_0x261c82(0x473);continue;case'3':questionsData=customData[_0x261c82(0x48c)];continue;case'4':document[_0x261c82(0x37d)](_0x261c82(0x286))[_0x261c82(0x2a8)]=questionsData[_0x261c82(0x350)];continue;case'5':document['getElementById']('quizHierarchy')[_0x261c82(0x2a8)]=hierarchy[_0x261c82(0x273)](_0x261c82(0x495));continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode='study',timer=null,timeRemaining=0x0,questionStartTime=Date[_0x261c82(0x30d)](),quizStartTime=Date[_0x261c82(0x30d)](),isQuizCompleted=![],questionStates=new Array(questionsData['length'])[_0x261c82(0x226)](null)[_0x261c82(0x43f)](()=>({'status':_0x261c82(0x459),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x261c82(0x350)]};function saveProgress(){const _0x47fcf9=_0x261c82,_0x5e27f1={'Lhkyk':_0x47fcf9(0x445),'qSJhR':_0x47fcf9(0x356)};if(isQuizCompleted)return;const _0x496fa1=JSON[_0x47fcf9(0x374)](localStorage[_0x47fcf9(0x3bd)](_0x5e27f1['Lhkyk']))||{};_0x496fa1[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x5e27f1['qSJhR'],'lastSeen':new Date()[_0x47fcf9(0x23b)]()},localStorage[_0x47fcf9(0x320)](_0x5e27f1[_0x47fcf9(0x2f3)],JSON[_0x47fcf9(0x1e4)](_0x496fa1));}function loadProgress(){const _0x31cb62=_0x261c82,_0x3e5e12={'FdCcZ':_0x31cb62(0x445),'NHBTr':_0x31cb62(0x212)},_0x1a0546=JSON[_0x31cb62(0x374)](localStorage[_0x31cb62(0x3bd)](_0x3e5e12['FdCcZ']))||{},_0x499c3a=_0x1a0546[quizFilename];if(_0x499c3a){const _0x2087ff=_0x3e5e12[_0x31cb62(0x487)][_0x31cb62(0x3f5)]('|');let _0x4e0927=0x0;while(!![]){switch(_0x2087ff[_0x4e0927++]){case'0':currentQuestionIndex=_0x499c3a[_0x31cb62(0x3df)];continue;case'1':currentMode=_0x499c3a[_0x31cb62(0x474)];continue;case'2':return!![];case'3':questionStates=_0x499c3a[_0x31cb62(0x493)];continue;case'4':console['log'](_0x31cb62(0x215));continue;case'5':stats=_0x499c3a['stats'];continue;}break;}}return![];}function clearProgress(){const _0x4535ca=_0x261c82,_0x295c1f={'gJYxJ':function(_0xf96986,_0x8fa117){return _0xf96986(_0x8fa117);},'WbhMr':function(_0x9e77f1,_0x517562){return _0x9e77f1+_0x517562;},'IGehS':_0x4535ca(0x311),'AsXey':_0x4535ca(0x460),'yQCOb':function(_0x80b8b4){return _0x80b8b4();},'IWTPo':_0x4535ca(0x445),'WbOoR':function(_0x11a66f,_0x55f1cb){return _0x11a66f===_0x55f1cb;},'RxDya':_0x4535ca(0x1f2),'KIswd':_0x4535ca(0x3d9)},_0x5524e4=JSON['parse'](localStorage[_0x4535ca(0x3bd)](_0x295c1f['IWTPo']))||{};if(_0x5524e4[quizFilename]){if(_0x295c1f[_0x4535ca(0x2b9)](_0x295c1f['RxDya'],_0x4535ca(0x2cf))){const _0x2cdb22=FhxrLY[_0x4535ca(0x241)](_0x44dc6b,FhxrLY[_0x4535ca(0x32d)](FhxrLY[_0x4535ca(0x29e)]+FhxrLY['AsXey'],');'));_0x53c6bd=FhxrLY[_0x4535ca(0x3ee)](_0x2cdb22);}else delete _0x5524e4[quizFilename],localStorage[_0x4535ca(0x320)](_0x295c1f[_0x4535ca(0x302)],JSON[_0x4535ca(0x1e4)](_0x5524e4)),console[_0x4535ca(0x395)](_0x295c1f[_0x4535ca(0x3fd)]);}}function markQuizAsCompleted(){const _0x444ff4=_0x261c82,_0x503e03={'ewJfn':'userHistory','dMTLy':_0x444ff4(0x408)},_0x3ddfef=JSON[_0x444ff4(0x374)](localStorage[_0x444ff4(0x3bd)](_0x503e03[_0x444ff4(0x25f)]))||{},_0x5b1901=questionsData[_0x444ff4(0x350)],_0x287efb=stats['correctAnswers']||0x0;_0x3ddfef[quizFilename]={'score':_0x287efb,'total':_0x5b1901,'status':_0x503e03[_0x444ff4(0x3f0)],'completedOn':new Date()[_0x444ff4(0x23b)]()},localStorage[_0x444ff4(0x320)](_0x503e03['ewJfn'],JSON['stringify'](_0x3ddfef));}const urlParams=new URLSearchParams(window[_0x261c82(0x361)][_0x261c82(0x290)]),startAt=parseInt(urlParams['get'](_0x261c82(0x2d1))),resume=urlParams['get'](_0x261c82(0x272))===_0x261c82(0x27d);function goBack(){const _0x55301c=_0x261c82,_0x621489={'bFzEW':_0x55301c(0x428)};if(!isQuizCompleted)saveProgress();window[_0x55301c(0x361)][_0x55301c(0x22b)]=document[_0x55301c(0x29b)]||_0x621489[_0x55301c(0x48e)];}function selectMode(_0x24b22b){const _0x5bac5a=_0x261c82,_0x2a974a={'UtKcp':'modeModal','ldKNK':function(_0x1acc42){return _0x1acc42();}};currentMode=_0x24b22b,document[_0x5bac5a(0x37d)](_0x2a974a['UtKcp'])[_0x5bac5a(0x380)]['display']=_0x5bac5a(0x27a),_0x2a974a[_0x5bac5a(0x351)](initializeQuiz);}function initializeQuiz(){const _0x2eb1ba=_0x261c82,_0x26ecfa={'NKklW':_0x2eb1ba(0x38e),'YuwtH':'markReviewBtn','JoGxw':'testModeReviewLegend','wlipi':_0x2eb1ba(0x3c1),'ignqr':function(_0x4d3397,_0x3bd0c7){return _0x4d3397===_0x3bd0c7;},'fQMFQ':_0x2eb1ba(0x1ec),'oCQbz':'statsBar','JkabU':_0x2eb1ba(0x27a),'vgcPI':'studyModeLegend','raTCy':_0x2eb1ba(0x48b),'BsOTm':'testModeLegend','RGxll':_0x2eb1ba(0x3db),'MqZUu':_0x2eb1ba(0x421),'rndZn':function(_0x7c26,_0x39abe8){return _0x7c26===_0x39abe8;},'GmbYG':_0x2eb1ba(0x2e1),'DKSzh':'timerContainer','bVUWQ':function(_0x23b935){return _0x23b935();},'vCwJk':function(_0x1c462a){return _0x1c462a();},'jheHt':function(_0x1c4543){return _0x1c4543();},'DEuSA':function(_0x40618a){return _0x40618a();}};quizStartTime=Date[_0x2eb1ba(0x30d)]();const _0x10d471=document['getElementById'](_0x26ecfa[_0x2eb1ba(0x1f8)]),_0x58934e=document[_0x2eb1ba(0x37d)](_0x26ecfa[_0x2eb1ba(0x378)]),_0x3ed183=document[_0x2eb1ba(0x37d)](_0x26ecfa[_0x2eb1ba(0x2f7)]),_0x185013=currentMode===_0x26ecfa[_0x2eb1ba(0x20f)]||_0x26ecfa[_0x2eb1ba(0x298)](currentMode,_0x26ecfa[_0x2eb1ba(0x406)]);document['getElementById'](_0x26ecfa['oCQbz'])[_0x2eb1ba(0x380)][_0x2eb1ba(0x2df)]=_0x185013?_0x26ecfa[_0x2eb1ba(0x331)]:'block',document['getElementById'](_0x26ecfa[_0x2eb1ba(0x1ca)])[_0x2eb1ba(0x380)][_0x2eb1ba(0x2df)]=_0x185013?_0x26ecfa[_0x2eb1ba(0x331)]:_0x26ecfa['raTCy'],document[_0x2eb1ba(0x37d)](_0x26ecfa['BsOTm'])[_0x2eb1ba(0x380)]['display']=_0x185013?_0x26ecfa[_0x2eb1ba(0x404)]:_0x26ecfa[_0x2eb1ba(0x331)],document[_0x2eb1ba(0x37d)](_0x26ecfa[_0x2eb1ba(0x42e)])['style'][_0x2eb1ba(0x2df)]=_0x185013?'block':_0x26ecfa[_0x2eb1ba(0x331)],_0x10d471['style'][_0x2eb1ba(0x2df)]=_0x185013?_0x26ecfa[_0x2eb1ba(0x331)]:'flex',_0x58934e[_0x2eb1ba(0x380)]['display']=_0x185013?_0x26ecfa[_0x2eb1ba(0x2ab)]:_0x26ecfa[_0x2eb1ba(0x331)],_0x3ed183[_0x2eb1ba(0x380)]['display']=_0x185013?_0x26ecfa[_0x2eb1ba(0x2ab)]:_0x26ecfa[_0x2eb1ba(0x331)],(_0x26ecfa[_0x2eb1ba(0x3b7)](currentMode,_0x26ecfa[_0x2eb1ba(0x35f)])||_0x26ecfa[_0x2eb1ba(0x298)](currentMode,_0x26ecfa['fQMFQ']))&&document[_0x2eb1ba(0x37d)](_0x26ecfa[_0x2eb1ba(0x218)])[_0x2eb1ba(0x235)]['remove']('hidden'),!isNaN(startAt)&&startAt>=0x0&&startAt<questionsData[_0x2eb1ba(0x350)]&&(currentQuestionIndex=startAt),_0x26ecfa[_0x2eb1ba(0x386)](loadBookmarkedQuestions),_0x26ecfa[_0x2eb1ba(0x335)](generateQuestionNav),_0x26ecfa['jheHt'](updateStats),_0x26ecfa[_0x2eb1ba(0x45c)](displayQuestion);}function generateQuestionNav(){const _0x73af1b=_0x261c82,_0x5b3130={'xIhZp':_0x73af1b(0x47f),'cuKRu':_0x73af1b(0x30a),'pmByg':function(_0x8d4f8d,_0x53f9ef){return _0x8d4f8d<_0x53f9ef;},'RELXw':function(_0x4526f8,_0x57b1fe){return _0x4526f8!==_0x57b1fe;},'fiBAH':'sTagp','ysvib':'button','TaRbX':_0x73af1b(0x346),'JUPoc':function(_0x120f37){return _0x120f37();}},_0x27f9b0=document[_0x73af1b(0x37d)](_0x5b3130[_0x73af1b(0x32f)]);_0x27f9b0[_0x73af1b(0x285)]='';for(let _0x3ae61b=0x0;_0x5b3130[_0x73af1b(0x20a)](_0x3ae61b,questionsData[_0x73af1b(0x350)]);_0x3ae61b++){if(_0x5b3130[_0x73af1b(0x28c)](_0x73af1b(0x432),_0x5b3130['fiBAH']))_0x382c6c[_0x73af1b(0x37d)](_0x73af1b(0x47b))[_0x73af1b(0x235)][_0x73af1b(0x355)](_0x5b3130['xIhZp']);else{const _0x3e0d3f=document['createElement'](_0x5b3130['ysvib']);_0x3e0d3f[_0x73af1b(0x2a8)]=_0x3ae61b+0x1,_0x3e0d3f[_0x73af1b(0x417)]=_0x5b3130['TaRbX'],_0x3e0d3f[_0x73af1b(0x3b8)]=()=>jumpToQuestion(_0x3ae61b),_0x3e0d3f['id']=_0x73af1b(0x3f2)+_0x3ae61b,_0x27f9b0[_0x73af1b(0x2b6)](_0x3e0d3f);}}_0x5b3130[_0x73af1b(0x47e)](updateQuestionNav);}function updateQuestionNav(){const _0x471506=_0x261c82,_0x53512b={'awmBe':'answered','uEpTt':function(_0x46904c,_0x52cbb0){return _0x46904c>=_0x52cbb0;},'nfUUq':function(_0x5ca444,_0x5d3d78){return _0x5ca444<_0x5d3d78;},'WiNsr':function(_0x417666,_0x33f3f7){return _0x417666-_0x33f3f7;},'Yomak':function(_0xe67a14){return _0xe67a14();},'WwWhu':_0x471506(0x365),'XgkLC':_0x471506(0x326),'pLACV':function(_0x5f4834,_0x86370e){return _0x5f4834===_0x86370e;},'MZxkZ':_0x471506(0x2fb),'jAVOW':_0x471506(0x392),'gksEH':_0x471506(0x1fa),'kBNwa':function(_0x286cd3,_0x3bed56){return _0x286cd3===_0x3bed56;},'thuqL':_0x471506(0x2e1),'ieKCa':_0x471506(0x208),'UHyjo':_0x471506(0x236),'SiwJt':function(_0x284fa,_0x516d10){return _0x284fa===_0x516d10;},'jCYwB':'incorrect','EgzoC':function(_0x334679,_0x21ccaa){return _0x334679!==_0x21ccaa;},'HknFn':_0x471506(0x1fe),'dgQJt':_0x471506(0x31d),'tyoUk':_0x471506(0x20e)};for(let _0x568e23=0x0;_0x53512b[_0x471506(0x3e9)](_0x568e23,questionsData[_0x471506(0x350)]);_0x568e23++){if(_0x53512b[_0x471506(0x26f)]===_0x53512b[_0x471506(0x304)])_0x39b4f9[_0x4c4d62]['status']=_0x53512b[_0x471506(0x282)],_0x46e5dc[_0x471506(0x32b)]++,_0x5a8f10[_0x471506(0x2fa)]--;else{const _0x2fc141=document[_0x471506(0x37d)](_0x471506(0x3f2)+_0x568e23),_0x145775=questionStates[_0x568e23];let _0x457852='';if(_0x53512b[_0x471506(0x261)](_0x568e23,currentQuestionIndex))_0x457852=_0x471506(0x31a);else{if(_0x145775[_0x471506(0x2b8)])_0x471506(0x2fb)===_0x53512b[_0x471506(0x2aa)]?_0x457852=_0x53512b[_0x471506(0x349)]:_0x4c7956[_0x471506(0x230)][_0x471506(0x465)](_0x549eb1=>{const _0x58a09f=_0x471506;if(_0x549eb1)_0x343003+=_0x58a09f(0x3d2)+_0x549eb1+_0x58a09f(0x34c);});else{if(_0x145775[_0x471506(0x457)])_0x457852=_0x471506(0x35a);else{if(_0x53512b[_0x471506(0x261)](currentMode,_0x53512b[_0x471506(0x24e)])||_0x53512b[_0x471506(0x456)](currentMode,_0x53512b[_0x471506(0x37e)])){if(_0x53512b['pLACV'](_0x145775[_0x471506(0x27f)],_0x53512b[_0x471506(0x489)]))_0x457852=_0x53512b[_0x471506(0x1c9)];else{if(_0x53512b[_0x471506(0x34d)](_0x145775['status'],_0x53512b[_0x471506(0x309)]))_0x457852=_0x471506(0x1d4);else _0x457852='nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20';}}else{if(_0x53512b[_0x471506(0x3eb)](_0x53512b[_0x471506(0x1c7)],_0x471506(0x46e))){if(_0x145775[_0x471506(0x23a)]!==null)_0x457852=_0x53512b['dgQJt'];else _0x457852=_0x53512b[_0x471506(0x2c6)];}else _0x53512b[_0x471506(0x3d0)](_0x61bb42,0x0)&&_0x53512b[_0x471506(0x3e9)](_0x317738,_0x261ce4[_0x471506(0x350)])&&(_0x2cd8fa&&(_0x146f4d[_0x3efc92][_0x471506(0x416)]+=_0x53512b[_0x471506(0x3b2)](_0x2dc7af[_0x471506(0x30d)](),_0x32c915)),_0x17357c=_0x14bc7b,_0x53512b[_0x471506(0x446)](_0x95e217),_0x53512b[_0x471506(0x446)](_0x20d0f7));}}}}_0x2fc141[_0x471506(0x417)]=_0x471506(0x431)+_0x457852;}}}function _0x4c18(_0x1283e2,_0x21bd8f){const _0x42d25d=_0x1a28();return _0x4c18=function(_0x330236,_0xa78927){_0x330236=_0x330236-0x1be;let _0x9e0df5=_0x42d25d[_0x330236];return _0x9e0df5;},_0x4c18(_0x1283e2,_0x21bd8f);}function jumpToQuestion(_0x3e0dbf){const _0x56da1b=_0x261c82,_0x84fca1={'EyssN':function(_0x4488c5,_0x28cec5){return _0x4488c5>=_0x28cec5;},'lRCfu':function(_0x49a80c,_0x143bff){return _0x49a80c<_0x143bff;},'IjwUy':function(_0xca4d76,_0x1453f9){return _0xca4d76-_0x1453f9;},'sIpdX':function(_0x2852e9){return _0x2852e9();}};_0x84fca1[_0x56da1b(0x42c)](_0x3e0dbf,0x0)&&_0x84fca1[_0x56da1b(0x2e0)](_0x3e0dbf,questionsData['length'])&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x56da1b(0x416)]+=_0x84fca1[_0x56da1b(0x40b)](Date[_0x56da1b(0x30d)](),questionStartTime)),currentQuestionIndex=_0x3e0dbf,_0x84fca1[_0x56da1b(0x3f8)](displayQuestion),_0x84fca1[_0x56da1b(0x3f8)](saveProgress));}function updateStats(){const _0x45811a=_0x261c82,_0x4d0ff0={'SQYrM':function(_0xc2f30a,_0xd4a48){return _0xc2f30a===_0xd4a48;},'OmLOq':function(_0x53f12a,_0x3aaf02){return _0x53f12a===_0x3aaf02;},'rUmTt':_0x45811a(0x41e),'QUQth':_0x45811a(0x32b),'mrBgA':function(_0xe1f485,_0x4d46b1){return _0xe1f485*_0x4d46b1;},'PZkaZ':function(_0x2444e1,_0xcf6a33){return _0x2444e1/_0xcf6a33;},'gHBMT':function(_0x4cb5f5,_0x19cbeb){return _0x4cb5f5+_0x19cbeb;},'emVdX':_0x45811a(0x416),'wMXfh':function(_0x42f21d,_0x3684d8){return _0x42f21d+_0x3684d8;}};if(_0x4d0ff0['SQYrM'](currentMode,_0x45811a(0x1fa))||_0x4d0ff0[_0x45811a(0x414)](currentMode,_0x45811a(0x2e1))){document[_0x45811a(0x37d)](_0x4d0ff0[_0x45811a(0x1cf)])[_0x45811a(0x2a8)]=stats['correctAnswers'],document[_0x45811a(0x37d)](_0x45811a(0x3fa))[_0x45811a(0x2a8)]=stats[_0x45811a(0x1d9)],document[_0x45811a(0x37d)](_0x4d0ff0[_0x45811a(0x243)])[_0x45811a(0x2a8)]=stats[_0x45811a(0x32b)];const _0x7a700e=stats['totalAttempted']>0x0?Math['round'](_0x4d0ff0[_0x45811a(0x2ae)](_0x4d0ff0[_0x45811a(0x204)](stats[_0x45811a(0x30c)],stats[_0x45811a(0x32b)]),0x64)):0x0;document[_0x45811a(0x37d)](_0x45811a(0x1e3))[_0x45811a(0x2a8)]=_0x4d0ff0[_0x45811a(0x222)](_0x7a700e,'%'),stats['totalTime']=questionStates[_0x45811a(0x31f)]((_0x4ba5b9,_0x33b0f4)=>_0x4ba5b9+_0x33b0f4[_0x45811a(0x416)],0x0);const _0x48c434=Math[_0x45811a(0x451)](stats[_0x45811a(0x38a)]/0x3e8),_0x2557ae=Math[_0x45811a(0x451)](_0x4d0ff0['PZkaZ'](_0x48c434,0x3c)),_0x20e177=_0x48c434%0x3c;document[_0x45811a(0x37d)](_0x4d0ff0[_0x45811a(0x3a5)])[_0x45811a(0x2a8)]=_0x4d0ff0[_0x45811a(0x217)](_0x4d0ff0[_0x45811a(0x217)](_0x2557ae,':'),_0x20e177[_0x45811a(0x265)]()[_0x45811a(0x39a)](0x2,'0'));}}function setupVideo(_0x40691b,_0x207549){const _0x24ef99=_0x261c82,_0x22205e={'FihMi':function(_0x4d3d4b){return _0x4d3d4b();},'bCyqX':'flex','zHGUK':'application/vnd.apple.mpegurl','pVaZf':function(_0x5d73fd,_0x2312a5){return _0x5d73fd===_0x2312a5;},'ZOMUR':_0x24ef99(0x292),'WXtjN':'jnkVg'};if(Hls['isSupported']()){const _0x3d4aa5=new Hls();_0x3d4aa5[_0x24ef99(0x291)](_0x207549),_0x3d4aa5[_0x24ef99(0x2ac)](_0x40691b);}else _0x40691b[_0x24ef99(0x3c2)](_0x22205e[_0x24ef99(0x2eb)])&&(_0x22205e[_0x24ef99(0x481)](_0x22205e[_0x24ef99(0x21f)],_0x22205e[_0x24ef99(0x3e5)])?(_0x22205e[_0x24ef99(0x2d7)](_0x561a92),_0x472efe[_0x24ef99(0x37d)](_0x24ef99(0x364))[_0x24ef99(0x380)]['display']=_0x22205e[_0x24ef99(0x252)]):_0x40691b[_0x24ef99(0x2b2)]=_0x207549);}function _0x1a28(){const _0x245e5e=['display','lRCfu','timed_study','gqYvk','nBOWM','lCwUy','qBank','text','rNdtm','AWswo','NgVPK','bCdfA','zHGUK','ykCdh','.option-button','evFsc','nIjlG','YIOJF','Ervto','__proto__','Lhkyk','DT1176835','pwrrR','dataset','JoGxw','OjhSB','RwqWR','notAttempted','GgwwK','scSDk','hoqmR','<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20of\x20the\x20above</span></p>','loGhl','questionMedia','JhLAJ','IWTPo','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20the\x20most\x20common\x20adverse\x20effect\x20associated\x20with\x20systemic\x20(especially\x20intravenous)\x20ganciclovir\x20therapy?</span></p>','XgkLC','wOyQO','<p><strong>Explanation:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240325dbf2fad0-0e53-4089-a3cb-e42c86f149cd.jpg\x22>','NxHhG','IBODR','jCYwB','questionNav','DT1176822','correctAnswers','now','MOnyg','vFWnD','mupZC','return\x20(function()\x20','HeBYr','<p><span\x20style=\x22font-size:12.0pt;\x22>Two</span></p>','oLzLy','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','<p><span\x20style=\x22font-size:12.0pt;\x22>Idiopathic\x20thrombocytopenic\x20purpura</span></p>','pShbA','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20not\x20an\x20ART\x20agent?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>1-b,\x202-a,\x203-d,\x204-c</span></p>','nav-btn-current','<p><span\x20style=\x22font-size:12.0pt;\x22>Oseltamivir</span></p>','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>Lopinavir\x20and\x20ritonavir\x20are\x20Protease\x20Inhibitors.</li>\x0a<li>Lopinavir\x20is\x20currently\x20formulated\x20only\x20in\x20combination\x20with\x20ritonavir,\x20which\x20inhibits\x20the\x20<strong>CYP3A-mediated\x20metabolism</strong>\x20of\x20lopinavir,\x20thereby\x20resulting\x20in\x20increased\x20exposure\x20to\x20lopinavir.</li>\x0a<li>In\x20addition\x20to\x20improved\x20patient\x20compliance\x20due\x20to\x20reduced\x20pill\x20burden,\x20lopinavir/ritonavir\x20is\x20generally\x20well\x20tolerated.</li>\x0a</ul>\x0a<p><strong>Protease\x20Inhibitors:</strong></p>\x0a<p><strong>Mechanism\x20of\x20Action:</strong></p>\x0a<p>PIs\x20inhibit\x20the\x20HIV\x20protease\x20enzyme,\x20which\x20is\x20essential\x20for\x20cleaving\x20the\x20Gag-Pol\x20polyprotein\x20during\x20the\x20final\x20stages\x20of\x20the\x20HIV\x20life\x20cycle.</p>\x0a<p><strong>Pharmacokinetics\x20&amp;\x20Boosting:</strong></p>\x0a<ul>\x0a<li><strong>PIs\x20are\x20often\x20co-administered</strong>\x20with:\x0a<ul>\x0a<li><strong>Ritonavir</strong>\x20(low-dose:\x20100-200\x20mg)\x20or</li>\x0a<li><strong>Cobicistat</strong>\x20(has\x20no\x20antiviral\x20activity)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Purpose\x20of\x20Boosting</strong>:<br\x20/>\x20Inhibits\x20<strong>CYP3A4</strong>,\x20increasing\x20the\x20serum\x20levels\x20and\x20half-life\x20of\x20the\x20primary\x20PI.<br\x20/>\x20Improves\x20efficacy\x20and\x20raises\x20the\x20<strong>genetic\x20barrier\x20to\x20resistance</strong>.</li>\x0a</ul>\x0a<p><strong>Adverse\x20Effects\x20of\x20Protease\x20Inhibitors\x20(PIs)</strong></p>\x0a<ul>\x0a<li><strong>Gastrointestinal:</strong>\x0a<ul>\x0a<li>Nausea</li>\x0a<li>Vomiting</li>\x0a<li>Diarrhea\x20(often\x20dose-limiting)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Metabolic:</strong>\x0a<ul>\x0a<li>Hyperglycemia</li>\x0a<li>Hyperlipidemia</li>\x0a<li>Insulin\x20resistance</li>\x0a</ul>\x0a</li>\x0a<li><strong>Morphologic\x20(Lipodystrophy\x20Syndrome):</strong>\x0a<ul>\x0a<li>Central\x20obesity</li>\x0a<li>Buffalo\x20hump\x20(dorsocervical\x20fat\x20pad)</li>\x0a<li>Facial\x20and\x20peripheral\x20fat\x20wasting\x20(lipoatrophy)</li>\x0a<li>Breast\x20enlargement</li>\x0a<li>Cushingoid\x20appearance</li>\x0a</ul>\x0a</li>\x0a<li><strong>Cardiovascular:</strong>\x0a<ul>\x0a<li>PR\x20interval\x20prolongation</li>\x0a<li>QT\x20interval\x20prolongation</li>\x0a<li>&uarr;\x20Cardiovascular\x20disease\x20risk\x20(notably\x20with\x20abacavir\x20and\x20lopinavir/ritonavir)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Hepatic:</strong>\x0a<ul>\x0a<li>Drug-induced\x20hepatitis</li>\x0a<li>Severe\x20hepatotoxicity\x20(especially\x20with\x20tipranavir/ritonavir)</li>\x0a<li>Unconjugated\x20hyperbilirubinemia\x20(especially\x20with\x20atazanavir)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Skeletal:</strong>\x0a<ul>\x0a<li>Potential\x20bone\x20loss\x20and\x20osteoporosis\x20(long-term\x20use;\x20under\x20investigation)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Hematologic:</strong>\x0a<ul>\x0a<li>Increased\x20spontaneous\x20bleeding\x20in\x20patients\x20with\x20hemophilia\x20A\x20or\x20B</li>\x0a<li>Risk\x20of\x20intracranial\x20hemorrhage\x20(noted\x20with\x20tipranavir/ritonavir)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Allergic\x20Reactions:</strong>\x0a<ul>\x0a<li><strong>Darunavir</strong>\x20is\x20a\x20sulfonamide\x20&rarr;\x20Use\x20with\x20caution\x20in\x20patients\x20with\x20sulfa\x20allergy</li>\x0a</ul>\x0a</li>\x0a</ul>','nav-btn-answered','<p><span\x20style=\x22font-size:12.0pt;\x22>None\x20of\x20the\x20above</span></p>','reduce','setItem','strokeDashoffset','20sgEMsb','progressBar','nvYnx','<p><strong>Explanation:</strong></p>\x0a<ol>\x0a<li><strong>Common\x20Adverse\x20Effect:</strong>\x20Systemic\x20ganciclovir\x20treatment,\x20especially\x20intravenous\x20use,\x20often\x20leads\x20to\x20myelosuppression.</li>\x0a<li><strong>Myelosuppression:</strong>\x20Myelosuppression\x20entails\x20reduced\x20blood\x20cell\x20production\x20by\x20the\x20bone\x20marrow,\x20causing\x20low\x20white\x20blood\x20cells,\x20red\x20blood\x20cells,\x20and\x20platelets.</li>\x0a<li><strong>Consequences\x20of\x20Myelosuppression:</strong>\x20This\x20condition\x20increases\x20the\x20risk\x20of\x20infections\x20(due\x20to\x20low\x20white\x20blood\x20cells),\x20causes\x20anemia-related\x20symptoms\x20(due\x20to\x20low\x20red\x20blood\x20cells),\x20and\x20can\x20lead\x20to\x20bleeding\x20tendencies\x20(due\x20to\x20low\x20platelet\x20count).</li>\x0a</ol>\x0a<p><strong>Adverse\x20Effects\x20of\x20Ganciclovir:</strong></p>\x0a<ul>\x0a<li><strong>Most\x20common</strong>:\x20<strong>Myelosuppression</strong>\x20(dose-limiting)</li>\x0a<li><strong>Others:</strong>\x0a<ul>\x0a<li>GI:\x20Nausea,\x20diarrhea<strong>(Option\x20B\x20ruled\x20out)</strong></li>\x0a<li>CNS:\x20Headache,\x20insomnia,\x20confusion,\x20seizures,\x20psychiatric\x20symptoms\x20<strong>(Option\x20D\x20ruled\x20out)</strong></li>\x0a<li>Skin:\x20Rash</li>\x0a<li>Liver:\x20Rare\x20<strong>hepatotoxicity(Option\x20A\x20ruled\x20out)</strong></li>\x0a<li>Eye\x20(intravitreal\x20use):\x20Vitreous\x20hemorrhage,\x20retinal\x20detachment</li>\x0a</ul>\x0a</li>\x0a<li><strong>Long-term\x20risks</strong>\x20(in\x20animals):\x0a<ul>\x0a<li><strong>Carcinogenic</strong>,\x20<strong>embryotoxic</strong>,\x20and\x20<strong>aspermatogenesis</strong></li>\x0a<li><strong>Mutagenic</strong>\x20in\x20mammalian\x20cells\x20(clinical\x20significance\x20unknown)</li>\x0a</ul>\x0a</li>\x0a</ul>','bTCNM','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','hDpXJ','YhPoD','totalAttempted','accuracyScore','WbhMr','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','cuKRu','solutionContainer','JkabU','julxa','JQYIt','SemsP','vCwJk','explanationVideoPlayer','yadFH','wSPZZ','ePivp','<p><strong>Explanation:</strong></p>\x0a<p>Acyclovir\x20requires\x20<strong>three\x20</strong>phosphorylation\x20steps\x20for\x20activation.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:\x20auto;\x20display:\x20block;\x20vertical-align:\x20middle;\x20border:\x200;\x22\x20src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509052d241e76-03a8-47a3-b7ca-1223cde3f9bf.jpg\x22>\x0a<ul>\x0a<li>Acyclovir\x20is\x20an\x20acyclic\x20guanosine\x20derivative\x20with\x20clinical\x20activity\x20against\x20HSV-1,\x20HSV-2,\x20and\x20VZV,\x20but\x20it\x20is\x20approximately\x2010\x20times\x20more\x20potent\x20against\x20HSV-1\x20and\x20HSV-2\x20than\x20against\x20VZV.\x20In\x20vitro\x20activity\x20against\x20Epstein-Barr\x20virus\x20(EBV),\x20cytomegalovirus\x20(CMV),\x20and\x20human\x20herpesvirus-6\x20(HHV-6)\x20is\x20present\x20but\x20weaker.</li>\x0a</ul>\x0a<p><strong>Acyclovir:</strong></p>\x0a<p><strong>Acyclovir</strong>\x20is\x20an\x20Acyclic\x20guanosine\x20nucleoside\x20analog,\x20which\x20is\x20an\x20Antiviral\x20drug\x20active\x20against\x20<strong>Herpesviridae</strong></p>\x0a<p><strong>Mechanism\x20of\x20Action:</strong></p>\x0a<p>Acyclovir\x20is\x20selectively\x20activated\x20in\x20infected\x20cells.</p>\x0a<ul>\x0a<li><strong>Requires\x20three\x20phosphorylation\x20steps\x20to\x20become\x20active:</strong>\x0a<ul>\x0a<li>Step\x201:\x20Viral\x20thymidine\x20kinase\x20&rarr;\x20acyclovir\x20monophosphate</li>\x0a<li>Step\x202\x20&amp;\x203:\x20Host\x20cell\x20kinases\x20&rarr;\x20acyclovir\x20diphosphate\x20&rarr;\x20triphosphate</li>\x0a</ul>\x0a</li>\x0a<li><strong>Antiviral\x20effects:</strong>\x0a<ul>\x0a<li>Inhibits\x20<strong>viral\x20DNA\x20polymerase</strong>\x20by\x20competing\x20with\x20deoxyGTP</li>\x0a<li>Causes\x20chain\x20termination\x20after\x20incorporation\x20into\x20viral\x20DNA</li>\x0a<li>Forms\x20an\x20irreversible\x20complex\x20with\x20viral\x20DNA\x20polymerase\x20and\x20DNA\x20template</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:\x20auto;\x20display:\x20block;\x20vertical-align:\x20middle;\x20border:\x200;\x22\x20src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509050e47b823-1a1c-4405-9063-73a700bd550e.jpg\x22>\x0a<p><strong>Pharmacokinetics</strong></p>\x0a<ul>\x0a<li>Oral\x20bioavailability:\x20Low\x20(15-20%),\x20unaffected\x20by\x20food</li>\x0a<li>Topical\x20use:\x20High\x20local\x20concentration,\x20no\x20systemic\x20levels</li>\x0a<li>IV\x20use:\x20Available\x20and\x20preferred\x20for\x20severe\x20infections</li>\x0a<li><strong>Excretion:\x20Renal\x20(glomerular\x20filtration\x20+\x20tubular\x20secretion)</strong></li>\x0a<li><strong>Half-life:</strong>\x0a<ul>\x0a<li>~2.5-3\x20hrs\x20(<strong>normal\x20renal\x20function</strong>)</li>\x0a<li>~20\x20hrs\x20(<strong>anuric\x20patients</strong>)</li>\x0a</ul>\x0a</li>\x0a<li>CNS\x20penetration:\x20CSF\x20levels\x20&asymp;20-50%\x20of\x20serum\x20levels</li>\x0a</ul>\x0a<p><strong>Clinical\x20Uses:</strong></p>\x0a<ul>\x0a<li><strong>HSV\x20infections:</strong>\x0a<ul>\x0a<li>Genital/orolabial\x20herpes</li>\x0a<li>Neonatal\x20HSV\x20(IV)</li>\x0a<li>Herpes\x20encephalitis\x20(IV)</li>\x0a</ul>\x0a</li>\x0a<li><strong>VZV\x20infections:</strong>\x0a<ul>\x0a<li>Chickenpox\x20(if\x20started\x20&lt;24\x20hrs\x20of\x20rash)</li>\x0a<li>Herpes\x20zoster\x20(if\x20&lt;72\x20hrs)</li>\x0a<li>Immunocompromised\x20VZV\x20&rarr;\x20IV\x20acyclovir</li>\x0a</ul>\x0a</li>\x0a<li><strong>Prophylaxis:</strong>\x0a<ul>\x0a<li>In\x20transplant/immunocompromised\x20patients</li>\x0a<li>In\x20pregnant\x20women\x20with\x20recurrent\x20genital\x20herpes\x20(from\x2036\x20weeks\x20of\x20gestation)</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Resistance</strong></p>\x0a<ul>\x0a<li>Due\x20to\x20Mutations\x20in\x20<strong>viral\x20thymidine\x20kinase\x20(UL23\x20gene)\x20</strong>and\x20Mutations\x20in\x20<strong>viral\x20DNA\x20polymerase</strong></li>\x0a<li><strong>Cross-resistance\x20with</strong>\x20Valacyclovir,\x20famciclovir,\x20ganciclovir</li>\x0a<li><strong>Alternative\x20agents\x20(do\x20not\x20require\x20viral\x20kinase):</strong>\x0a<ul>\x0a<li>Foscarnet</li>\x0a<li>Cidofovir</li>\x0a<li>Trifluridine</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Adverse\x20Effects</strong></p>\x0a<ul>\x0a<li><strong>Common\x20(oral):</strong>\x20Nausea,\x20diarrhea,\x20headache</li>\x0a<li><strong>IV-specific\x20(rare):</strong>\x0a<ul>\x0a<li><strong>Nephrotoxicity</strong>:\x20Crystalline\x20nephropathy,\x20interstitial\x20nephritis</li>\x0a<li><strong>Neurotoxicity</strong>:\x20Tremors,\x20delirium,\x20seizures</li>\x0a<li><strong>Hematologic:</strong>\x20Reversible\x20neutropenia</li>\x0a</ul>\x0a</li>\x0a<li><strong>High-dose\x20animal\x20toxicity:</strong>\x20Chromosomal\x20damage,\x20testicular\x20atrophy\x20(not\x20seen\x20in\x20long-term\x20human\x20use)</li>\x0a</ul>','JWUvU','createElement','WJGFq','<div\x20class=\x22mt-4\x22><img\x20src=\x22','KmJMo','QKqCQ','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2034-year-old\x20male\x20patient\x20came\x20to\x20the\x20OPD\x20with\x20the\x20complaint\x20of\x20bilateral\x20genital\x20vesicles,\x20fever,\x20and\x20itching.\x20He\x20is\x20a\x20known\x20case\x20of\x20HIV\x20and\x20has\x20been\x20on\x20ART\x20for\x20the\x20last\x204\x20years.\x20So,\x20he\x20is\x20diagnosed\x20with\x20genital\x20HSV\x20infection\x20in\x20HIV.\x20There\x20are\x20three\x20nucleoside\x20analogues\x20licensed\x20for\x20the\x20treatment\x20of\x20HSV\x20and\x20VZV.\x20Which\x20of\x20the\x20following\x20are\x20three\x20agents?</span></p>','No\x20questions\x20available\x20for\x20this\x20quiz.','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>30-35\x20mg/kg</span></p>','questionIndex','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','question_video','jAVOW','question_audio','tRWQW','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','SiwJt','\x22\x20data-option-index=\x22','xSaSQ','length','ldKNK','findIndex','myvvZ','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','add','incomplete','solutionText','trace','wuKqI','nav-btn-marked-review','<p><strong>Explanation:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403255a9b4cad-5498-4283-9fc2-90feb4168161.jpg\x22>','spORZ','Antiviral\x20Agents\x20Herpes\x20Hiv\x20Influenza\x20Hbv\x20And\x20Hcv','BhACC','GmbYG','Lopud','location','notAttemptedResult','CUyeX','modeModal','ukljI','yzQIo','vYHaO','WXimJ','WFoTh','QrLTp','HmzcG','Syzrn','UyILG','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','<p><span\x20style=\x22font-size:12.0pt;\x22>Acyclovir,\x20valacyclovir,\x20famciclovir</span></p>','BZyEZ','KmrEq','IUwhe','ocjpo','parse','mjBZZ','kgbaK','intermediate','YuwtH','<p><strong>Explanation:</strong></p>\x0a<p><strong>Preferred\x20IV\x20drug\x20for\x20acyclovir-resistant\x20HSV\x20is\x20Foscarnet</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403253feeab37-9d79-4e67-8212-04e4506a602b.jpg\x22>\x0a<p><strong>Resistance\x20to\x20acyclovir:\x20</strong></p>\x0a<ul>\x0a<li>Due\x20to\x20Mutations\x20in\x20<strong>viral\x20thymidine\x20kinase\x20(UL23\x20gene)\x20</strong>and\x20Mutations\x20in\x20<strong>viral\x20DNA\x20polymerase</strong></li>\x0a<li><strong>Cross-resistance\x20with</strong>\x20Valacyclovir,\x20famciclovir,\x20ganciclovir</li>\x0a<li><strong>Alternative\x20agents\x20(do\x20not\x20require\x20viral\x20kinase):</strong>\x0a<ul>\x0a<li>Foscarnet</li>\x0a<li>Cidofovir</li>\x0a<li>Trifluridine</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Foscarnet:</strong></p>\x0a<p>Foscarnet\x20is\x20an\x20Inorganic\x20<strong>pyrophosphate\x20analog</strong></p>\x0a<p><strong>Mechanism\x20of\x20Action:</strong></p>\x0a<ul>\x0a<li>Directly\x20inhibits<strong>\x20Herpesvirus\x20DNA\x20polymerase,\x20RNA\x20polymerase,\x20and\x20HIV\x20reverse\x20transcriptase</strong></li>\x0a<li>Binds\x20to\x20the\x20pyrophosphate-binding\x20site\x20of\x20enzymes\x20&rarr;\x20prevents\x20cleavage\x20of\x20pyrophosphate\x20from\x20deoxynucleotide\x20triphosphates\x20&rarr;\x20inhibits\x20DNA\x20synthesis</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905018401a5-72b7-4d97-97c9-b18e5a693de6.jpg\x22>\x0a<p><strong>Antiviral\x20Spectrum:\x20</strong>Effective\x20against\x20<strong>HSV</strong>,\x20<strong>VZV,\x20CMV</strong>\x20(including\x20ganciclovir-resistant),\x20<strong>EBV</strong>,\x20<strong>HHV-6</strong>,\x20<strong>HHV-8,\x20HIV-1</strong>,\x20<strong>HIV-2</strong></p>\x0a<p><strong>Formulation\x20&amp;\x20Administration:</strong></p>\x0a<ul>\x0a<li>Only\x20IV\x20(oral\x20use\x20limited\x20by\x20poor\x20bioavailability\x20and\x20GI\x20intolerance)</li>\x0a<li>Use\x20an\x20infusion\x20pump\x20and\x20saline\x20preloading\x20to\x20reduce\x20nephrotoxicity</li>\x0a<li>Intravitreally\x20used\x20for\x20CMV\x20retinitis</li>\x0a</ul>\x0a<p><strong>Pharmacokinetics</strong></p>\x0a<ul>\x0a<li>CSF\x20levels:\x20~43-67%\x20of\x20plasma</li>\x0a<li>Plasma\x20half-life:\x203-7\x20hours</li>\x0a<li>Bone\x20deposition:\x20up\x20to\x2030%\x20(half-life\x20of\x20months)</li>\x0a<li>Renal\x20clearance\x20proportional\x20to\x20creatinine\x20clearance\x20&rarr;\x20dose\x20adjustment\x20required</li>\x0a<li>50%\x20removed\x20via\x20hemodialysis</li>\x0a</ul>\x0a<p><strong>Adverse\x20Effects</strong></p>\x0a<ul>\x0a<li><strong>Nephrotoxicity</strong>:\x0a<ul>\x0a<li>Prevent\x20with\x20<strong>hydration</strong></li>\x0a<li>Avoid\x20with\x20other\x20nephrotoxic\x20drugs\x20(e.g.,\x20amphotericin\x20B,\x20aminoglycosides)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Electrolyte\x20Imbalances</strong>:\x0a<ul>\x0a<li>Hypo-/hypercalcemia</li>\x0a<li>Hypo-/hyperphosphatemia</li>\x0a<li>Hypokalemia,\x20hypomagnesemia</li>\x0a</ul>\x0a</li>\x0a<li><strong>Genital\x20ulcerations</strong>:\x0a<ul>\x0a<li>Due\x20to\x20high\x20urinary\x20concentration\x20of\x20ionized\x20drug</li>\x0a</ul>\x0a</li>\x0a<li><strong>CNS\x20toxicity</strong>:\x0a<ul>\x0a<li>Headache,\x20<strong>hallucinations</strong>,\x20<strong>seizures</strong></li>\x0a<li>Seizure\x20risk\x20&uarr;\x20with\x20<strong>imipenem</strong></li>\x0a</ul>\x0a</li>\x0a<li><strong>Hematologic</strong>:\x0a<ul>\x0a<li>Anemia\x20(worse\x20with\x20<strong>zidovudine</strong>)</li>\x0a<li>&uarr;\x20Liver\x20enzymes</li>\x0a<li>Fatigue</li>\x0a</ul>\x0a</li>\x0a<li><strong>Carcinogenicity</strong>:\x0a<ul>\x0a<li><strong>Chromosomal\x20damage</strong>\x20noted\x20in\x20preclinical\x20studies</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>S/E\x20of\x20Foscarnet,\x20Cedofovir\x20-\x20Similar\x20to\x20Tenofovir-\x20<strong>Pneumonic\x20Neck\x20Of\x20Femur\x20(NOF)</strong></p>\x0a<ul>\x0a<li>Nephrotoxciity</li>\x0a<li>Osteoporosis</li>\x0a<li>Fanconi\x20syndrome</li>\x0a</ul>\x0a<p>Unique\x20s/e\x20of\x20Foscarnet\x20-\x20Genital\x20ulceration</p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2035-year-old\x20female\x20patient\x20with\x20recurrent\x20herpes\x20labialis\x20came\x20to\x20the\x20OPD\x20for\x20the\x205th\x20episode\x20of\x20herpes\x20labialis.\x20She\x20was\x20prescribed\x20acyclovir\x20topical\x20ointment\x205\x20times\x20daily\x20for\x204\x20days.\x20How\x20many\x20phosphorylation\x20steps\x20are\x20required\x20for\x20the\x20activation\x20of\x20acyclovir?</span></p>','aVBRT','boTje','getElementById','thuqL','<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20the\x20above</span></p>','style','MhfvK','DT1176849','vIfoC','<p><span\x20style=\x22font-size:12.0pt;\x22>Tenofovir\x20+\x20Emtricitabine\x20+\x20Efavirenz</span></p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','bVUWQ','BEzAD','bookmarkText','gBveD','totalTime','<p><span\x20style=\x22font-size:12.0pt;\x22>Ganciclovir</span></p>','xoycY','questionReviewSection','bookmarkBtn','Bookmarked','Marked','warn','nav-btn-bookmarked','cmovA','avgTimeResult','log','3158144aqJrIz','<p><span\x20style=\x22font-size:12.0pt;\x22>Emtricitabine</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20drug\x20is\x20used\x20as\x20a\x20single\x20dose\x20for\x20the\x20prevention\x20of\x20HIV\x20from\x20mother\x20to\x20neonate\x20at\x20the\x20onset\x20of\x20labour?</span></p>','ttdMl','padStart','No\x20solution\x20available.','querySelectorAll','bind','hjHkZ','aLYir','25vugZBx','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','wAEgd','pbyar','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','emVdX','NgATj','iAvzM','<p><strong>Explanation:</strong></p>\x0a<p><strong>Pre-Exposure\x20Prophylaxis\x20(PrEP)\x20for\x20HIV:</strong></p>\x0a<p>Pre-exposure\x20prophylaxis\x20(PrEP)\x20is\x20the\x20use\x20of\x20antiretroviral\x20drugs\x20by\x20HIV-negative\x20individuals\x20at\x20high\x20risk\x20of\x20HIV\x20exposure\x20to\x20prevent\x20infection.</p>\x0a<p><strong>Recommended\x20PrEP\x20Regimens\x20(as\x20per\x20NACO\x20&amp;\x20WHO\x202024\x20guidelines)</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509054dd9ee37-c379-46bf-81eb-a7c694327194.png\x22>\x0a<p><strong>Indications\x20for\x20PrEP</strong></p>\x0a<ul>\x0a<li>Serodiscordant\x20couples\x20(one\x20partner\x20HIV-positive)</li>\x0a<li>MSM\x20(men\x20who\x20have\x20sex\x20with\x20men)</li>\x0a<li>Transgender\x20individuals\x20are\x20at\x20risk</li>\x0a<li>Sex\x20workers</li>\x0a<li>IV\x20drug\x20users\x20sharing\x20needles</li>\x0a<li>Individuals\x20with\x20multiple\x20sexual\x20partners\x20who\x20do\x20not\x20use\x20condoms</li>\x0a</ul>','TjJqv','Correct','kqbjs','timeDisplay','XnjsM','<p><span\x20style=\x22font-size:12.0pt;\x22>Thrombotic\x20thrombocytopenic\x20purpura</span></p>','incorrect','hRTVY','getAttribute','WiNsr','<p><strong>Explanation:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509056ba93ad3-a979-4e80-95a9-6f61c640bfe3.png\x22><br>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403225c2eaa7e-0b82-4c39-8eb1-18373730f4bd.jpg\x22>','YcCce','gJiWb','rnNGN','rndZn','onclick','<p><span\x20style=\x22font-size:12.0pt;\x22>1-a,\x202-c,\x203-d,\x204-b</span></p>','hgGfo','niKQd','CgMyF','getItem','solutionVideo','GsJpV','HBSZM','test','canPlayType','LGQMS','YLAVB','<p><span\x20style=\x22font-size:12.0pt;\x22>Penciclovir</span></p>','LMmgk','dREDz','currentQuestion','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2035-year-old\x20male\x20patient\x20with\x20HIV\x20presents\x20with\x20chronic\x20diarrhea\x20and\x20is\x20started\x20on\x20ART.\x20While\x20collecting\x20a\x20blood\x20sample,\x20an\x20intern\x20sustains\x20a\x20needle-stick\x20injury.\x20He\x20reports\x20immediately\x20to\x20the\x20ART\x20center\x20for\x20post-exposure\x20prophylaxis\x20(PEP).\x20Which\x20of\x20the\x20following\x20drug\x20combinations\x20is\x20recommended\x20for\x20PEP?</span></p>','Not\x20Attempted','<p><span\x20style=\x22font-size:12.0pt;\x22>CCR4\x20receptor\x20antagonist</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>10-20\x20mg/kg</span></p>','izOMt','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','gray','uEpTt','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','ZmXLw','ArrowLeft','<p><strong>Explanation:</strong></p>\x0a<p><strong>The\x20CCR4\x20receptor\x20antagonist\x20</strong>is\x20not\x20used\x20in\x20HIV\x20therapy.\x20<strong>Maraviroc,\x20a\x20CCR5\x20receptor\x20antagonis</strong>t,\x20is\x20used\x20in\x20ART.\x20CCR4\x20is\x20not\x20a\x20recognized\x20target\x20in\x20HIV\x20treatment.</p>\x0a<p><strong>Antiretroviral\x20Therapy\x20(ART)\x20agents:</strong></p>\x0a<ol>\x0a<li><strong>NRTIs\x20(Nucleoside/Nucleotide\x20Reverse\x20Transcriptase\x20Inhibitors)</strong>\x0a<ul>\x0a<li><strong>Mechanism:\x20</strong>Act\x20as\x20faulty\x20DNA\x20building\x20blocks,\x20inhibiting\x20reverse\x20transcription.</li>\x0a<li><strong>Examples:\x20</strong>Zidovudine\x20(AZT),\x20Lamivudine\x20(3TC),\x20Tenofovir\x20(TDF,\x20TAF),\x20Emtricitabine\x20(FTC),\x20Abacavir\x20(ABC),\x20Stavudine\x20(d4T),\x20Didanosine\x20(ddI)</li>\x0a</ul>\x0a</li>\x0a<li><strong>NNRTIs\x20(Non-Nucleoside\x20Reverse\x20Transcriptase\x20Inhibitors)</strong>\x0a<ul>\x0a<li><strong>Mechanism:\x20</strong>Bind\x20to\x20and\x20inhibit\x20reverse\x20transcriptase\x20at\x20a\x20different\x20site\x20than\x20NRTIs.</li>\x0a<li><strong>Examples:\x20</strong>Efavirenz,\x20Nevirapine,\x20Etravirine,\x20Rilpivirine,\x20Doravirine</li>\x0a</ul>\x0a</li>\x0a<li><strong>PIs\x20(Protease\x20Inhibitors)</strong>\x0a<ul>\x0a<li><strong>Mechanism:\x20</strong>Inhibits\x20the\x20HIV\x20protease\x20enzyme,\x20preventing\x20viral\x20maturation.</li>\x0a<li><strong>Examples:\x20</strong>Lopinavir,\x20Ritonavir\x20(used\x20mainly\x20as\x20a\x20booster),\x20Atazanavir,\x20Darunavir,\x20Indinavir,\x20Saquinavir</li>\x0a</ul>\x0a</li>\x0a<li><strong>INSTIs\x20(Integrase\x20Strand\x20Transfer\x20Inhibitors)</strong>\x0a<ul>\x0a<li><strong>Mechanism:\x20</strong>Inhibits\x20the\x20HIV\x20integrase\x20enzyme,\x20blocking\x20the\x20integration\x20of\x20viral\x20DNA\x20into\x20host\x20DNA.</li>\x0a<li><strong>Examples:\x20</strong>Dolutegravir,\x20Raltegravir,\x20Bictegravir,\x20Elvitegravir</li>\x0a</ul>\x0a</li>\x0a<li><strong>Entry\x20and\x20Fusion\x20Inhibitors</strong>\x0a<ul>\x0a<li>Fusion\x20Inhibitors:\x20Enfuvirtide\x20(T-20)\x20blocks\x20the\x20fusion\x20of\x20HIV\x20with\x20the\x20host\x20cell.</li>\x0a<li>CCR5\x20Receptor\x20Antagonists\x20(Entry\x20Inhibitors):\x20Maraviroc\x20blocks\x20the\x20CCR5\x20co-receptor\x20(not\x20CCR4).</li>\x0a</ul>\x0a</li>\x0a<li><strong>Post-Attachment\x20Inhibitor:\x20</strong>Ibalizumab,\x20a\x20monoclonal\x20antibody\x20used\x20for\x20multidrug-resistant\x20HIV.</li>\x0a<li><strong>CXCR4\x20inhibitor:\x20</strong>Plerixafor</li>\x0a</ol>','<p><span\x20style=\x22font-size:12.0pt;\x22>Three</span></p>','bFIDZ','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','Previous\x20progress\x20cleared.','border-gray-600','submitSection','CJxQk','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','aISJp','currentQuestionIndex','5274414JYEjEr','UIZxJ','solutionImages','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2028-year-old\x20woman\x20presents\x20with\x20the\x20sudden\x20onset\x20of\x20high-grade\x20fever,\x20dry\x20cough,\x20sore\x20throat,\x20and\x20myalgia\x20during\x20the\x20peak\x20flu\x20season.\x20She\x20reports\x20recent\x20contact\x20with\x20a\x20co-worker\x20diagnosed\x20with\x20H1N1\x20(Swine\x20flu).\x20What\x20is\x20the\x20most\x20commonly\x20used\x20antiviral\x20drug\x20for\x20the\x20treatment\x20of\x20this\x20condition?</span></p>','NsDfa','WXtjN','DT1176839','<p><span\x20style=\x22font-size:12.0pt;\x22>Colon\x20carcinoma</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Interferon\x20alfa-2b</span></p>','nfUUq','<p><span\x20style=\x22font-size:12.0pt;\x22>Tenofovir\x20Disoproxil\x20Fumarate\x20+\x20Lamivudine\x20+\x20Dolutegravir</span></p>','EgzoC','filter','NOObJ','yQCOb','lOpPf','dMTLy','JZPRX','navBtn_','addEventListener','uaJKM','split','hierarchy','green','sIpdX','jkDNN','incorrectCount','WHoDP','<p><span\x20style=\x22font-size:12.0pt;\x22>Fevipiravir</span></p>','KIswd','quizFile','DT1176812','PzPbs','<p><span\x20style=\x22font-size:12.0pt;\x22>NNRTIs</span></p>','video[data-src]','lqfUL','raTCy','qmjbl','fQMFQ','apply','completed','DT1176805','endsWith','IjwUy','dUonq','lFdBl','4718082WrHoUL','markReviewBtn','EYzXL','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','lIjTy','xlxYe','OmLOq','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','timeSpent','className','incorrectResult','xfhwU','<p><span\x20style=\x22font-size:12.0pt;\x22>5-10\x20mg/kg</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>GI\x20intolerance</span></p>','totalTimeResult','qGJFk','correctCount','explanation_video','QBdNi','flex','USGaC','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20newborn\x20child\x20is\x20admitted\x20to\x20the\x20NICU\x20for\x20phototherapy\x20for\x20neonatal\x20jaundice.\x20He\x20develops\x20a\x20fever\x20on\x20the\x204th\x20day.\x20So,\x20blood\x20culture\x20investigation\x20is\x20done.\x20Blood\x20culture\x20is\x20positive\x20for\x20HSV-1\x20viral\x20infection.\x20The\x20paediatrician\x20wants\x20to\x20start\x20intravenous\x20acyclovir\x20for\x20treatment.\x20What\x20is\x20the\x20correct\x20dose\x20of\x20acyclovir\x20every\x208\x20hours\x20for\x20the\x20treatment\x20of\x20neonatal\x20HSV\x20infection?</span></p>','ixcGG','uJakl','keydown','JBqSU','index.html','markReviewText','BQZQw','DWzJa','EyssN','fSlSK','RGxll','\x22\x20data-src=\x22','<p><span\x20style=\x22font-size:12.0pt;\x22>Zidovudine</span></p>','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','sTagp','rxurX','explanation_images','TuXoY','border-green-500','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','ZTiri','DT1176848','JKrsy','kVMnW','HNuak','KKpPU','mGGhw','map','choices','<p><span\x20style=\x22font-size:12.0pt;\x22>Lamivudine</span></p>','Option\x20','bnOic','XoBta','userHistory','Yomak','3|1|0|2|4|5','PmaJD','constructor','ZmMBn','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2025-year-old\x20patient\x20came\x20to\x20the\x20OPD\x20with\x20complaints\x20of\x20decreased\x20urine,\x20difficulty\x20in\x20breathing,\x20and\x20bilateral\x20pedal\x20oedema.\x20USG\x20was\x20s/o\x20CRF\x20grade\x20-V.\x20He\x20underwent\x20a\x20series\x20of\x20investigations,\x20and\x20a\x20renal\x20transplant\x20was\x20done.\x20Which\x20anti-viral\x20agent\x20is\x20useful\x20in\x20this\x20pt.\x20for\x20CMV\x20infection\x20prevention?</span></p>','VFqAs','bTvrn','cFRnH','PLTfh','fUcLG','floor','iShGI','ltleq','SMvkn','aWGnM','kBNwa','markedForReview','CsKkX','not_attempted','open','KfOvR','DEuSA','BWWtq','optionsContainer','uUWum','{}.constructor(\x22return\x20this\x22)(\x20)','explanation_audio_hin','wmFPF','YpMpi','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>Three\x20oral\x20nucleoside\x20analogues\x20are\x20licensed\x20for\x20the\x20treatment\x20of\x20HSV\x20and\x20VZV\x20infections:\x20<strong>acyclovir,\x20valacyclovir,\x20and\x20famciclovir.</strong></li>\x0a<li>They\x20have\x20similar\x20mechanisms\x20of\x20action\x20and\x20comparable\x20indications\x20for\x20clinical\x20use;\x20all\x20are\x20well\x20tolerated.\x20Acyclovir\x20has\x20been\x20the\x20most\x20extensively\x20studied</li>\x0a<li>It\x20was\x20licensed\x20first\x20and\x20is\x20the\x20only\x20one\x20of\x20the\x20three\x20that\x20is\x20available\x20for\x20intravenous\x20use\x20in\x20the\x20United\x20States.</li>\x0a<li>Comparative\x20trials\x20have\x20demonstrated\x20similar\x20efficacies\x20of\x20these\x20three\x20agents\x20for\x20the\x20treatment\x20of\x20HSV,\x20but\x20modest\x20superiority\x20of\x20<strong>famciclovir\x20and\x20valacyclovir\x20</strong>for\x20the\x20treatment\x20of\x20herpes\x20zoster\x20infections.</li>\x0a<li><strong>Acyclovir</strong>\x0a<ul>\x0a<li>First-line\x20drug\x20for\x20HSV\x20and\x20VZV</li>\x0a<li>Inhibits\x20viral\x20DNA\x20polymerase\x20after\x20phosphorylation\x20by\x20viral\x20thymidine\x20kinase</li>\x0a</ul>\x0a</li>\x0a<li><strong>Valacyclovir</strong>\x0a<ul>\x0a<li>Prodrug\x20of\x20acyclovir\x20(better\x20oral\x20bioavailability)</li>\x0a<li>Converted\x20to\x20acyclovir\x20in\x20the\x20body</li>\x0a</ul>\x0a</li>\x0a<li><strong>Famciclovir</strong>\x0a<ul>\x0a<li>Prodrug\x20of\x20penciclovir</li>\x0a<li>Also\x20used\x20in\x20HSV\x20and\x20VZV\x20infections</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Genital\x20Herpes</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509054a7f3a80-2e07-4d5f-b6a7-45337131b286.png\x22>\x0a<p><strong>In\x20Pregnancy:</strong>\x20Suppressive\x20therapy\x20should\x20begin\x20at\x2036\x20weeks.</p>\x0a<p>Acyclovir\x20400\x20mg\x20TID\x20<strong>or</strong>\x20Valacyclovir\x20500\x20mg\x20BID</p>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Acyclovir,\x20penciclovir,\x20famciclovir(Option\x20A):</strong>\x20Penciclovir\x20is\x20<strong>only\x20topical</strong>\x20and\x20not\x20commonly\x20used\x20systemically\x20for\x20genital\x20HSV.</p>\x0a<p><strong>Valacyclovir,\x20penciclovir,\x20famciclovir(Option\x20C):\x20</strong>Again,\x20<strong>penciclovir</strong>\x20is\x20topical\x20and\x20not\x20a\x20systemic\x20treatment.</p>\x0a<p><strong>Valacyclovir,\x20famciclovir,\x20lamivudine(Option\x20D):\x20Lamivudine</strong>\x20is\x20<strong>not\x20used\x20for\x20HSV\x20or\x20VZV</strong>;\x20it\x27s\x20a\x20reverse\x20transcriptase\x20inhibitor\x20used\x20in\x20<strong>HIV</strong>\x20and\x20<strong>HBV</strong>\x20treatment.</p>','forEach','<p><span\x20style=\x22font-size:12.0pt;\x22>1.\x20Lopinavir\x20is\x20currently\x20formulated\x20only\x20in\x20combination\x20with\x20ritonavir<br>2.\x20It\x20inhibits\x20CYP2A-mediated\x20metabolism\x20of\x20lopinavir</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Hepatotoxicity</span></p>','title','kCrKs','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','NMAgp','<p><span\x20style=\x22font-size:12.0pt;\x22>Testing\x20to\x20rule\x20out\x20the\x20HLA-B5701\x20allele\x20is\x20recommended\x20before\x20initiating\x20therapy</span></p>','lGGzk','PDHRN','prototype','FFpxF','cFsxQ','BmFTr','\x20-\x20Brain\x20And\x20Scalpel','currentMode','CqCcS','HgYdu','qHTWG','tJTHX','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>A\x20single\x20dose\x20of\x20<strong>nevirapine</strong>\x20(200\x20mg)\x20is\x20effective\x20in\x20the\x20prevention\x20of\x20transmission\x20of\x20HIV\x20from\x20mother\x20to\x20newborn\x20when\x20administered\x20to\x20women\x20<strong>at\x20the\x20onset\x20of\x20labor\x20</strong>and\x20followed\x20by\x20a\x20<strong>2\x20mg/kg\x20oral\x20dose\x20to\x20the\x20neonate\x20within\x203\x20days\x20after\x20delivery.</strong></li>\x0a<li>There\x20is\x20no\x20evidence\x20of\x20human\x20teratogenicity.\x20However,\x20resistance\x20has\x20been\x20documented\x20after\x20this\x20single\x20dose.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090591de0329-150c-4c28-a726-fabd86f1c52b.jpg\x22>\x0a<p><strong>Infant\x20Prophylaxis\x20(Post-Delivery)</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905b38ac5e9-3219-44c5-a039-aecd05f749b3.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Zidovudine(Option\x20B):\x20</strong>Used\x20in\x20<strong>combination\x20regimens</strong>\x20for\x20PMTCT\x20but\x20<strong>not\x20as\x20a\x20single\x20dose</strong>\x20at\x20labor\x20onset.</p>\x0a<p><strong>Tenofovir(Option\x20C):\x20</strong>Part\x20of\x20<strong>combination\x20ART\x20regimens</strong>\x20during\x20pregnancy,\x20not\x20used\x20as\x20a\x20single\x20dose\x20at\x20labor\x20onset.</p>\x0a<p><strong>Sofosbuvir(Option\x20D):\x20</strong>An\x20<strong>antiviral\x20for\x20Hepatitis\x20C</strong>,\x20<strong>not\x20used\x20in\x20HIV\x20prophylaxis</strong>.</p>','vSnfk','performanceModal','red','zGtSe','JUPoc','hidden','DT1176824','pVaZf','timerContainer','explanation_audio_eng','PNcFd','fromCharCode','toggle','NHBTr','EDDzr','ieKCa','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','block','questions','yTKGr','bFzEW','RMqpa','bmhvM','IkIiK','aYxZO','questionStates','oaxJa','\x20>\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Sentences\x201\x20and\x202\x20are\x20both\x20False</span></p>','XXkcs','JRFbB','oabWD','<p><strong>Explanation:</strong></p>\x0a<p>According\x20to\x20<strong>NACO\x202023\x20guidelines</strong>\x20for\x20<strong>HIV\x20PEP</strong>,\x20the\x20recommended\x20regimen\x20is:</p>\x0a<ul>\x0a<li><strong>Tenofovir\x20Disoproxil\x20Fumarate\x20(TDF)</strong>\x20300\x20mg</li>\x0a<li><strong>Lamivudine\x20(3TC)</strong>\x20300\x20mg</li>\x0a<li><strong>Dolutegravir\x20(DTG)</strong>\x2050\x20mg\x20once\x20daily</li>\x0a<li><strong>Duration:</strong>\x2028\x20days</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905d55550e6-a358-41e8-9bfd-1f6a3911eb46.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Zidovudine\x20+\x20Lamivudine\x20+\x20Nevirapine</strong>:</p>\x0a<p>Outdated.\x20Nevirapine\x20is\x20<strong>not\x20recommended</strong>\x20due\x20to\x20<strong>hepatotoxicity\x20risk</strong>\x20and\x20poor\x20safety\x20in\x20PEP.</p>\x0a<p><strong>Tenofovir\x20+\x20Emtricitabine\x20+\x20Efavirenz</strong>:</p>\x0a<p>Previously\x20used,\x20but\x20<strong>Efavirenz</strong>\x20has\x20<strong>CNS\x20side\x20effects</strong>,\x20and\x20<strong>DTG\x20is\x20now\x20preferred</strong>\x20for\x20its\x20high\x20potency\x20and\x20tolerability.</p>\x0a<p><strong>Abacavir\x20+\x20Lamivudine\x20+\x20Rilpivirine</strong>:</p>\x0a<p>Not\x20recommended\x20for\x20PEP.\x20<strong>Abacavir\x20requires\x20HLA-B*5701\x20testing</strong>,\x20and\x20<strong>Rilpivirine</strong>\x20has\x20restrictions\x20like\x20food\x20requirements\x20and\x20can\x27t\x20be\x20used\x20with\x20high\x20viral\x20loads.</p>','OiMAh','vLzvI','laQwV','Ttdvz','AxPhM','dlmcn','PcOvZ','pxlaj','OFchy','HknFn','removeItem','UHyjo','vgcPI','QPnrF','njiOl','KJrAF','<p><span\x20style=\x22font-size:12.0pt;\x22>Sentence\x201\x20and\x202\x20both\x20are\x20True,\x20and\x202\x20is\x20the\x20correct\x20reason\x20for\x201</span></p>','rUmTt','<p><span\x20style=\x22font-size:12.0pt;\x22>Match\x20the\x20following\x20for\x20ART\x20agents.<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024032259b83918-43da-42cc-913c-491a288ea328.jpg\x22></span></p>','WBOad','NeZvO','GONoG','nav-btn-incorrect','fByFm','console','qlyQA','jFJHf','incorrectAnswers','hNmSh','.m3u8','EVnQE','div','znFJz','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','qHOiM','DOMContentLoaded','BwTPK','accuracy','stringify','ZPtPS','solutionAudio','ebqPm','<p><span\x20style=\x22font-size:12.0pt;\x22>Sentences\x201\x20and\x202\x20both\x20are\x20True,\x20but\x202\x20is\x20not\x20the\x20correct\x20reason\x20for\x201</span></p>','DT1176841','aJzBm','nywNQ','timed_exam','jOZbe','orZXU','JSHlK','wNsVq','JhjiI','wvXbn','1023504fTRnqC','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>HBV\x20infection\x20in\x20the\x20United\x20States:\x20five\x20oral\x20nucleoside/nucleotide\x20analogues\x20(<strong>lamivudine</strong>,\x20adefovir\x20dipivoxil,\x20<strong>tenofovir</strong>,\x20entecavir,\x20telbivudine)\x20and\x20two\x20injectable\x20interferon\x20drugs\x20(<strong>interferon\x20alfa-2b</strong>,\x20pegylated\x20interferon\x20alfa-2a)</li>\x0a</ul>\x0a<p><strong>First-Line\x20Antiviral\x20Drugs\x20for\x20HBV</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090502bf14b9-4b45-41e9-b470-e619127b2e4c.png\x22>\x0a<p><strong>Other\x20Drugs:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905a1399877-da9c-45ad-8d93-8c098df04057.png\x22>','qmnit','-600\x20text-white\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20as\x20pre-exposure\x20prophylaxis\x20of\x20HIV?</span></p>','NKklW','name','study','width','EQBTc','IRSRV','AVDbI','<p><span\x20style=\x22font-size:12.0pt;\x22>One</span></p>','pop','replace','JdVYO','DuKtY','PZkaZ','EnMkj','tUVHV','EFara','correct','DT1176843','pmByg','not-attempted','BEWDd','YGVFx','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','wlipi','kTOOR','<p><span\x20style=\x22font-size:12.0pt;\x22>Nevirapine</span></p>','3|5|0|1|4|2','EHiAZ','udWuw','Progress\x20loaded.','fIHyN','wMXfh','DKSzh','pscLi','PSpqP','<p><span\x20style=\x22font-size:12.0pt;\x22>2-5\x20mg/kg</span></p>','FvFQT','custom_quiz.html','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','ZOMUR','<p><span\x20style=\x22font-size:12.0pt;\x22>Docosanol</span></p>','reload','gHBMT','PqTHC','BoWGv','<p><span\x20style=\x22font-size:12.0pt;\x22>Valacyclovir,\x20penciclovir,\x20famciclovir</span></p>','fill','data-option-index','(((.+)+)+)+$','PMsip','cRHaJ','href','guZjn','selected','Mark\x20for\x20Review','TlwWa','question_images','Xlwgk','disabled','gOErW','<p><span\x20style=\x22font-size:12.0pt;\x22>Sentence\x201\x20is\x20True,\x20but\x20Sentence\x202\x20is\x20False</span></p>','classList','nav-btn-correct','fSTUM','XEDmG','SMhwL','selectedAnswer','toISOString','<p><span\x20style=\x22font-size:12.0pt;\x22>1-c,\x202-a,\x203-d,\x204-d</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Valacyclovir,\x20famciclovir,\x20lamivudine</span></p>','YyEHy','<p><span\x20style=\x22font-size:12.0pt;\x22>Acyclovir,\x20penciclovir,\x20famciclovir</span></p>','ROntb','gJYxJ','<p><span\x20style=\x22font-size:12.0pt;\x22>Myelosuppression</span></p>','QUQth','rmxzh','xdzfl','gJSCx','AYAKT','URMjB','qKxSK','<p><span\x20style=\x22font-size:12.0pt;\x22>Central\x20nervous\x20system\x20toxicity</span></p>','LhAPn','dzMsD','Factual','gksEH','WEXWh','table','Zbrsd','bCyqX','1687746jBtoKf','ajnbY','qnzLN','luqng','answered','aJUWp','WzoGT','Otojg','Efjur','SDSPE','NGooY','MKuiZ','ewJfn','mzUGw','pLACV','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>The\x20neuraminidase\x20inhibitors<strong>\x20oseltamivir\x20and\x20zanamivir</strong>,\x20analogues\x20of\x20sialic\x20acid,\x20interfere\x20with\x20the\x20release\x20of\x20progeny\x20<strong>influenza\x20virus</strong>\x20from\x20infected\x20host\x20cells,\x20thus\x20halting\x20the\x20spread\x20of\x20infection\x20within\x20the\x20respiratory\x20tract.</li>\x0a<li>These\x20agents\x20competitively\x20and\x20reversibly\x20interact\x20with\x20the\x20active\x20enzyme\x20site\x20to\x20inhibit\x20viral\x20neuraminidase\x20activity\x20at\x20low\x20nanomolar\x20concentrations.</li>\x0a<li>Inhibition\x20of\x20viral\x20neuraminidase\x20results\x20in\x20clumping\x20of\x20newly\x20released\x20influenza\x20virions\x20with\x20each\x20other\x20and\x20the\x20membrane\x20of\x20the\x20infected\x20cell.</li>\x0a</ul>\x0a<p><strong>Oseltamivir:</strong></p>\x0a<p>Class\x20of<strong>\x20Neuraminidase\x20inhibitors\x20</strong>(along\x20with\x20Zanamivir)<strong>.\x20</strong>Analog\x20of\x20sialic\x20acid</p>\x0a<h4><strong>Mechanism\x20of\x20Action:</strong></h4>\x0a<ul>\x0a<li>Inhibits\x20viral\x20neuraminidase\x20of\x20<strong>Influenza\x20A\x20&amp;\x20B</strong></li>\x0a<li>Prevents\x20the\x20release\x20of\x20progeny\x20virions\x20from\x20infected\x20cells</li>\x0a<li>Causes\x20clumping\x20of\x20virions\x20&rarr;\x20reduces\x20the\x20spread\x20of\x20infection</li>\x0a</ul>\x0a<p><strong>Clinical\x20Use:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:\x20auto;\x20display:\x20block;\x20vertical-align:\x20middle;\x20border:\x200;\x22\x20src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509052ccf6fc8-ac46-4eee-9239-004ea9297e7e.png\x22>\x0a<p><strong>Pharmacokinetics:</strong></p>\x0a<ul>\x0a<li><strong>Prodrug</strong>\x20(activated\x20by\x20hepatic\x20esterases)</li>\x0a<li><strong>Oral\x20bioavailability:</strong>\x20~80%</li>\x0a<li><strong>Distribution:</strong>\x20Plasma,\x20sinus,\x20middle\x20ear\x20fluid</li>\x0a<li><strong>Half-life:</strong>\x206-10\x20hours</li>\x0a<li><strong>Excretion:</strong>\x20Renal\x20(glomerular\x20filtration\x20+\x20tubular\x20secretion)</li>\x0a<li><strong>Drug\x20interaction:</strong>\x20Probenecid\x20&darr;\x20reduces\x20renal\x20clearance\x20by\x20~50%</li>\x0a</ul>\x0a<p><strong>Adverse\x20Effects:</strong></p>\x0a<ul>\x0a<li><strong>Common:\x20</strong>Nausea,\x20vomiting,\x20Headache,\x20fatigue,\x20diarrhea\x20(more\x20common\x20in\x20prophylaxis)</li>\x0a<li><strong>Rare:\x20</strong>Rash,\x20<strong>Neuropsychiatric\x20events</strong>\x20(delirium,\x20self-injury),\x20especially\x20in\x20adolescents\x20(notably\x20in\x20Japan)</li>\x0a<li><strong>Caution:\x20Renal\x20insufficiency:</strong>\x20Dose\x20adjustment\x20required</li>\x0a</ul>\x0a<p><strong>Classification\x20of\x20Anti-Influenza\x20Drugs</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:\x20auto;\x20display:\x20block;\x20vertical-align:\x20middle;\x20border:\x200;\x22\x20src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905a2cf2a6e-9d25-4a79-bce7-5ac8caadfe99.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Favipiravir(Option\x20B)</strong>:\x20Used\x20for\x20severe\x20or\x20refractory\x20viral\x20infections,\x20<strong>not\x20first-line</strong>\x20for\x20seasonal\x20influenza.</p>\x0a<p><strong>Remdesivir(Option\x20C)</strong>:\x20Approved\x20for\x20<strong>COVID-19</strong>,\x20<strong>not\x20used\x20for\x20influenza</strong>.</p>','includes','isArray','toString','contains','OhYnV','DocTutorial','XwSJz','zqKyu','<p><span\x20style=\x22font-size:12.0pt;\x22>Zidovudine\x20+\x20Lamivudine\x20+\x20Nevirapine</span></p>','customQuizData','<p><span\x20style=\x22font-size:12.0pt;\x22>Patient\x20taking\x20abacavir\x20advised\x20to\x20take\x20alcohol\x20along\x20with\x20it</span></p>','Lwcvv','WwWhu','pBGeD','ebMta','resume','join','Hbypl','QgiIF','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','goBwU','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','uuHHG','none','mWioO','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','true','push','status','questionText','nFybk','awmBe','dzCuM','21oBEqbX','innerHTML','totalQuestions','xQfxP','correct_choice_id','iWDNy','qTZoJ','cBcPJ','RELXw','key','LVkoO','Bookmark','search','loadSource','OAGYs','gFBcc','BtcNk','xPhYG','<p><span\x20style=\x22font-size:12.0pt;\x22>Foscarnet</span></p>','uGMZo','ignqr','vUJsD','DaaKO','referrer','<p><span\x20style=\x22font-size:12.0pt;\x22>1-d,\x202-b,\x203-a,\x204-c</span></p>','qhZFu','IGehS','reviewQuestionsContainer','262824owXYmR','rfORV','YxrNx','oqSyw','EbRdy','kfrJF','DT1176836','kzufS','textContent','scoreCircle','MZxkZ','MqZUu','attachMedia','fEsBO','mrBgA','afNzo','966536YITEIk','DT1176842','src','MQMzn','KZaBD','pathname','appendChild','<p><span\x20style=\x22font-size:12.0pt;\x22>Tenofovir</span></p>','bookmarked','WbOoR','QRBfc','WuvYt','</span><span>','Wfoaj','wYURo','<p><span\x20style=\x22font-size:12.0pt;\x22>NRTIs</span></p>','wyhaw','remove','ioIGf','oCuJb','XMAOl','<p><span\x20style=\x22font-size:12.0pt;\x22>Four</span></p>','tyoUk','YCEST','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','UOYHQ','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','LzTFR','Sdtoj','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','closest','iiXbr','solution','startAt','IAZIy','jAWnC','Ydyap','eVNuS','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','FihMi','bottom','toLowerCase','cZhZJ','</span></div>','11TArlTv','PqghZ','HrtZY'];_0x1a28=function(){return _0x245e5e;};return _0x1a28();}function displayQuestion(){const _0x4eb1cb=_0x261c82,_0x5889d0={'YyEHy':function(_0x297567,_0xa4e53e){return _0x297567+_0xa4e53e;},'HrtZY':_0x4eb1cb(0x22d),'vLzvI':_0x4eb1cb(0x2ed),'loGhl':function(_0x4bcae7,_0x399548){return _0x4bcae7(_0x399548);},'nbSCY':'data-option-index','qHTWG':function(_0x3ae182,_0x5514b3){return _0x3ae182!==_0x5514b3;},'AxPhM':'VBsvA','NsDfa':function(_0x29f93a,_0x5408a4){return _0x29f93a+_0x5408a4;},'ttdMl':function(_0x1de0fa,_0x317df4){return _0x1de0fa===_0x317df4;},'rmxzh':_0x4eb1cb(0x442),'xPhYG':function(_0x24f376,_0x5d3b3b){return _0x24f376+_0x5d3b3b;},'NgATj':'1|4|3|5|2|0','rxurX':'Progress\x20loaded.','WJGFq':function(_0x4c13d4,_0x59eedb){return _0x4c13d4!==_0x59eedb;},'vIfoC':function(_0x25dbac,_0x2e59a1){return _0x25dbac(_0x2e59a1);},'qnzLN':function(_0x540676,_0x488f9c){return _0x540676(_0x488f9c);},'ocjpo':function(_0xb52136,_0x1e86d7){return _0xb52136(_0x1e86d7);},'kahyI':function(_0x1040f1,_0x4bfb5b){return _0x1040f1===_0x4bfb5b;},'ajnbY':_0x4eb1cb(0x342),'JKrsy':function(_0x507cb7,_0x29267b){return _0x507cb7*_0x29267b;},'xfhwU':function(_0x25ed1d,_0x4fde21){return _0x25ed1d/_0x4fde21;},'XMAOl':function(_0x297491,_0xb71421){return _0x297491+_0xb71421;},'jNiFS':_0x4eb1cb(0x323),'IAZIy':function(_0x88ba73,_0xf27ebc){return _0x88ba73+_0xf27ebc;},'LzTFR':function(_0x569c16,_0x59d1e1){return _0x569c16+_0x59d1e1;},'luqng':function(_0x28880c){return _0x28880c();},'FRhCf':'prevBtn','rnNGN':function(_0x3a7349,_0x16f057){return _0x3a7349===_0x16f057;},'hoqmR':_0x4eb1cb(0x330),'uJakl':_0x4eb1cb(0x47f),'DWzJa':_0x4eb1cb(0x280),'QRBfc':'No\x20question\x20text\x20available','qlyQA':'optionsContainer','PSpqP':'click','PqTHC':_0x4eb1cb(0x2e1),'tfrxS':function(_0xa26c2e,_0x286895){return _0xa26c2e===_0x286895;},'DaaKO':_0x4eb1cb(0x1ec),'ixcGG':_0x4eb1cb(0x372)};if(!questionsData||_0x5889d0['kahyI'](questionsData[_0x4eb1cb(0x350)],0x0)){document[_0x4eb1cb(0x37d)](_0x4eb1cb(0x280))[_0x4eb1cb(0x285)]=_0x5889d0[_0x4eb1cb(0x254)];return;};const _0x4a38e4=questionsData[currentQuestionIndex];questionStartTime=Date[_0x4eb1cb(0x30d)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x40c2e3=_0x5889d0[_0x4eb1cb(0x43a)](_0x5889d0[_0x4eb1cb(0x419)](_0x5889d0[_0x4eb1cb(0x2c4)](currentQuestionIndex,0x1),questionsData['length']),0x64);document[_0x4eb1cb(0x37d)](_0x5889d0['jNiFS'])[_0x4eb1cb(0x380)][_0x4eb1cb(0x1fb)]=_0x5889d0[_0x4eb1cb(0x2d2)](_0x40c2e3,'%'),document[_0x4eb1cb(0x37d)](_0x4eb1cb(0x3c8))[_0x4eb1cb(0x2a8)]=_0x5889d0[_0x4eb1cb(0x2cb)](currentQuestionIndex,0x1),_0x5889d0[_0x4eb1cb(0x256)](updateQuestionNav),document['getElementById'](_0x5889d0['FRhCf'])[_0x4eb1cb(0x232)]=_0x5889d0[_0x4eb1cb(0x3b6)](currentQuestionIndex,0x0),document[_0x4eb1cb(0x37d)](_0x5889d0[_0x4eb1cb(0x2fd)])['classList'][_0x4eb1cb(0x355)](_0x5889d0[_0x4eb1cb(0x425)]),document[_0x4eb1cb(0x37d)](_0x5889d0[_0x4eb1cb(0x42b)])['innerHTML']=_0x4a38e4[_0x4eb1cb(0x2e6)]||_0x5889d0[_0x4eb1cb(0x2ba)];let _0x54467d='';if(_0x4a38e4['question_audio'])_0x54467d+=_0x4eb1cb(0x46a)+_0x4a38e4[_0x4eb1cb(0x34a)]+_0x4eb1cb(0x21e);if(_0x4a38e4[_0x4eb1cb(0x348)])_0x54467d+=_0x4eb1cb(0x3d8)+_0x4a38e4[_0x4eb1cb(0x348)]+_0x4eb1cb(0x278);_0x4a38e4[_0x4eb1cb(0x230)]&&_0x4a38e4['question_images']['forEach'](_0x4cfb62=>{const _0x24cae1=_0x4eb1cb,_0x17ad5e={'iHQnD':function(_0x362467,_0x14d3ee){const _0x2a8a33=_0x4c18;return _0x5889d0[_0x2a8a33(0x23e)](_0x362467,_0x14d3ee);},'JdVYO':_0x5889d0[_0x24cae1(0x2de)],'NGooY':_0x5889d0[_0x24cae1(0x1bf)],'NeZvO':function(_0x5dedb4,_0x4be9eb){const _0xed89e6=_0x24cae1;return _0x5889d0[_0xed89e6(0x2ff)](_0x5dedb4,_0x4be9eb);},'Efjur':_0x5889d0['nbSCY']};if(_0x5889d0[_0x24cae1(0x477)](_0x5889d0[_0x24cae1(0x1c2)],_0x5889d0['AxPhM'])){const _0x1cda6e={'zucJi':function(_0x5b3dcf,_0x5e8e95){return _0x17ad5e['iHQnD'](_0x5b3dcf,_0x5e8e95);},'aPVXW':function(_0x3fff1f,_0xad93c4){return _0x3fff1f===_0xad93c4;},'dREDz':'div','nIjlG':_0x17ad5e[_0x24cae1(0x202)],'cZhZJ':function(_0x291b78,_0x348505){return _0x291b78+_0x348505;},'fByFm':_0x24cae1(0x442),'wNXKw':_0x17ad5e[_0x24cae1(0x25d)],'SDSPE':function(_0x5ca24e,_0x3e5e0f){const _0xcf5eb6=_0x24cae1;return _0x17ad5e[_0xcf5eb6(0x1d2)](_0x5ca24e,_0x3e5e0f);},'ZTiri':_0x17ad5e[_0x24cae1(0x25b)]};_0x114cc6[_0x24cae1(0x440)][_0x24cae1(0x465)]((_0x10098b,_0x4d7c6f)=>{const _0x232f21=_0x24cae1,_0x352f19=_0x4ef83e[_0x232f21(0x485)](_0x1cda6e['zucJi'](0x41,_0x4d7c6f)),_0x493d21=_0x1cda6e['aPVXW'](_0xa15575,_0x4d7c6f),_0x27d71e=_0x4f14b4[_0x232f21(0x33c)](_0x1cda6e[_0x232f21(0x3c7)]);_0x27d71e['innerHTML']=_0x232f21(0x354)+(_0x493d21?_0x1cda6e[_0x232f21(0x2ef)]:'')+_0x232f21(0x34e)+_0x4d7c6f+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x352f19+_0x232f21(0x415)+(_0x10098b['text']||_0x1cda6e[_0x232f21(0x2da)](_0x1cda6e[_0x232f21(0x1d5)],_0x1cda6e[_0x232f21(0x2da)](_0x4d7c6f,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0xd1a24f['appendChild'](_0x27d71e);}),_0x87ca9[_0x24cae1(0x3f3)]('click',function(_0x5a8f1b){const _0x37ab0a=_0x24cae1,_0x41bf94=_0x5a8f1b['target'][_0x37ab0a(0x2ce)](_0x1cda6e['wNXKw']);if(_0x41bf94){const _0x5a06de=_0x1cda6e[_0x37ab0a(0x25c)](_0x1a432d,_0x41bf94[_0x37ab0a(0x3b1)](_0x1cda6e[_0x37ab0a(0x438)]));_0x1cda6e['SDSPE'](_0x2396eb,_0x5a06de);}});}else{if(_0x4cfb62)_0x54467d+=_0x24cae1(0x3d2)+_0x4cfb62+_0x24cae1(0x34c);}});document[_0x4eb1cb(0x37d)](_0x4eb1cb(0x300))['innerHTML']=_0x54467d;const _0x22a55f=document[_0x4eb1cb(0x37d)](_0x5889d0[_0x4eb1cb(0x1d7)]);_0x22a55f[_0x4eb1cb(0x285)]='',_0x22a55f[_0x4eb1cb(0x235)][_0x4eb1cb(0x2c1)]('answered');_0x4a38e4[_0x4eb1cb(0x440)]&&Array[_0x4eb1cb(0x264)](_0x4a38e4[_0x4eb1cb(0x440)])&&(_0x4a38e4[_0x4eb1cb(0x440)][_0x4eb1cb(0x465)]((_0x4265c6,_0x1ef37e)=>{const _0x9ba615=_0x4eb1cb,_0xdbec1f=String['fromCharCode'](_0x5889d0[_0x9ba615(0x3e4)](0x41,_0x1ef37e)),_0x5b98c5=_0x5889d0[_0x9ba615(0x399)](selectedOption,_0x1ef37e),_0x364986=document[_0x9ba615(0x33c)](_0x9ba615(0x1dd));_0x364986[_0x9ba615(0x285)]=_0x9ba615(0x354)+(_0x5b98c5?_0x5889d0[_0x9ba615(0x2de)]:'')+_0x9ba615(0x34e)+_0x1ef37e+_0x9ba615(0x276)+_0xdbec1f+_0x9ba615(0x415)+(_0x4265c6[_0x9ba615(0x2e6)]||_0x5889d0[_0x9ba615(0x3e4)](_0x5889d0[_0x9ba615(0x244)],_0x5889d0[_0x9ba615(0x295)](_0x1ef37e,0x1)))+_0x9ba615(0x2d6),_0x22a55f[_0x9ba615(0x2b6)](_0x364986);}),_0x22a55f[_0x4eb1cb(0x3f3)](_0x5889d0[_0x4eb1cb(0x21a)],function(_0x59f8e9){const _0x26b113=_0x4eb1cb,_0x5df929={'KmrEq':_0x5889d0[_0x26b113(0x3a6)],'hDpXJ':_0x5889d0[_0x26b113(0x433)]};if(_0x5889d0[_0x26b113(0x33d)](_0x26b113(0x324),_0x26b113(0x324))){const _0x4fca94=_0x5df929[_0x26b113(0x371)][_0x26b113(0x3f5)]('|');let _0x4fd1bd=0x0;while(!![]){switch(_0x4fca94[_0x4fd1bd++]){case'0':return!![];case'1':_0x117238=_0x1874d6[_0x26b113(0x493)];continue;case'2':_0x39a049['log'](_0x5df929[_0x26b113(0x329)]);continue;case'3':_0x4ebab3=_0x5c5d52[_0x26b113(0x3df)];continue;case'4':_0x9ecc01=_0x13b577['stats'];continue;case'5':_0x49517f=_0x3b9c92[_0x26b113(0x474)];continue;}break;}}else{const _0x2eaf70=_0x59f8e9['target'][_0x26b113(0x2ce)](_0x5889d0[_0x26b113(0x1bf)]);if(_0x2eaf70){const _0x89acfe=_0x5889d0['vIfoC'](parseInt,_0x2eaf70[_0x26b113(0x3b1)](_0x26b113(0x227)));_0x5889d0[_0x26b113(0x255)](selectOption,_0x89acfe);}}}));_0x5889d0[_0x4eb1cb(0x256)](updateBookmarkButton),_0x5889d0['luqng'](updateMarkReviewButton);if((_0x5889d0[_0x4eb1cb(0x3b6)](currentMode,_0x5889d0[_0x4eb1cb(0x223)])||_0x5889d0['tfrxS'](currentMode,_0x5889d0[_0x4eb1cb(0x29a)]))&&!isQuizCompleted){if(_0x5889d0['qHTWG'](_0x5889d0[_0x4eb1cb(0x424)],_0x5889d0['ixcGG'])){const _0xdda550=_0x5889d0[_0x4eb1cb(0x383)](_0x44bc6d,_0x47986b[_0x4eb1cb(0x3b1)](_0x4eb1cb(0x227)));_0x5889d0[_0x4eb1cb(0x373)](_0x4870e4,_0xdda550);}else _0x5889d0['luqng'](startTimer);}}function selectOption(_0xbbdadb){const _0x385ca9=_0x261c82,_0x59b9df={'mupZC':function(_0x4a18e4){return _0x4a18e4();},'lCwUy':function(_0x4eca4d,_0x244f87){return _0x4eca4d(_0x244f87);},'iAvzM':function(_0x17e105,_0x506a71){return _0x17e105===_0x506a71;},'hRTVY':_0x385ca9(0x445),'BoWGv':_0x385ca9(0x229),'Zbrsd':_0x385ca9(0x22d),'yzQIo':_0x385ca9(0x45e),'oaxJa':function(_0x3c8f8e,_0x517980){return _0x3c8f8e!==_0x517980;},'SMhwL':_0x385ca9(0x43d),'qmjbl':'ElyUm','uGMZo':function(_0x57c680,_0x3b468e){return _0x57c680-_0x3b468e;},'lGeLN':'.option-button','QBdNi':function(_0x85367d,_0x2f835c){return _0x85367d===_0x2f835c;},'ltleq':_0x385ca9(0x257),'Rxrfw':function(_0xea83ed){return _0xea83ed();}},_0x26ffd8=document[_0x385ca9(0x37d)](_0x59b9df[_0x385ca9(0x366)]);if(_0x26ffd8[_0x385ca9(0x235)][_0x385ca9(0x266)](_0x385ca9(0x257)))return;questionStartTime&&(_0x59b9df[_0x385ca9(0x494)](_0x59b9df[_0x385ca9(0x239)],_0x59b9df[_0x385ca9(0x405)])?(questionStates[currentQuestionIndex][_0x385ca9(0x416)]+=_0x59b9df[_0x385ca9(0x297)](Date[_0x385ca9(0x30d)](),questionStartTime),questionStartTime=Date[_0x385ca9(0x30d)]()):(_0x4a166c--,_0x59b9df[_0x385ca9(0x310)](_0x5bfd15),_0x842d25<=0x0&&(_0x59b9df[_0x385ca9(0x2e4)](_0x487f27,_0x25aac1),_0x59b9df[_0x385ca9(0x3a7)](_0x5ee342,_0x385ca9(0x1ec))?_0x1da7f8():_0x59b9df[_0x385ca9(0x310)](_0x4c39ef)))),selectedOption=_0xbbdadb,questionStates[currentQuestionIndex][_0x385ca9(0x23a)]=_0xbbdadb,document[_0x385ca9(0x39c)](_0x59b9df['lGeLN'])[_0x385ca9(0x465)]((_0x4ce37d,_0x1b9df8)=>{const _0x3e9b98=_0x385ca9;if(_0x59b9df[_0x3e9b98(0x224)]!==_0x59b9df[_0x3e9b98(0x224)]){if(_0x227b71)return;const _0x3652a4=_0x2c793e[_0x3e9b98(0x374)](_0x4260f5['getItem'](_0x59b9df['hRTVY']))||{};_0x3652a4[_0x1293ee]={'questionStates':_0x12e1d3,'stats':_0x564356,'currentQuestionIndex':_0x196e58,'currentMode':_0x422bfb,'status':_0x3e9b98(0x356),'lastSeen':new _0x6533b5()['toISOString']()},_0x8e9d1f['setItem'](_0x59b9df[_0x3e9b98(0x3b0)],_0x78521[_0x3e9b98(0x1e4)](_0x3652a4));}else _0x4ce37d['classList'][_0x3e9b98(0x486)](_0x59b9df[_0x3e9b98(0x251)],_0x59b9df['iAvzM'](_0x1b9df8,_0xbbdadb));}),_0x59b9df[_0x385ca9(0x3a7)](currentMode,_0x385ca9(0x1fa))||_0x59b9df[_0x385ca9(0x3a7)](currentMode,_0x385ca9(0x2e1))?processAnswer():(_0x59b9df[_0x385ca9(0x420)](questionStates[currentQuestionIndex][_0x385ca9(0x27f)],_0x385ca9(0x459))&&(questionStates[currentQuestionIndex][_0x385ca9(0x27f)]=_0x59b9df[_0x385ca9(0x453)],stats['totalAttempted']++,stats[_0x385ca9(0x2fa)]--),_0x59b9df[_0x385ca9(0x310)](updateQuestionNav)),_0x59b9df['Rxrfw'](saveProgress);}function processAnswer(){const _0xd046a5=_0x261c82,_0xff61c8={'THmon':function(_0xde9ec1,_0x30e569){return _0xde9ec1===_0x30e569;},'jkmnM':_0xd046a5(0x459),'xdzfl':_0xd046a5(0x208),'PnewM':function(_0x58a0b1,_0x18d593){return _0x58a0b1(_0x18d593);}},_0x3ffe4f=questionsData[currentQuestionIndex],_0x4fb9af=_0x3ffe4f[_0xd046a5(0x288)];if(_0xff61c8['THmon'](selectedOption,null))return;const _0x5b2704=_0x3ffe4f[_0xd046a5(0x440)][selectedOption],_0x277b5a=_0x5b2704['id']===_0x4fb9af;if(questionStates[currentQuestionIndex][_0xd046a5(0x27f)]===_0xff61c8['jkmnM']){stats[_0xd046a5(0x32b)]++,stats['notAttempted']--;if(_0x277b5a)stats[_0xd046a5(0x30c)]++;else stats[_0xd046a5(0x1d9)]++;}questionStates[currentQuestionIndex][_0xd046a5(0x27f)]=_0x277b5a?_0xff61c8[_0xd046a5(0x245)]:_0xd046a5(0x3af),updateStats(),_0xff61c8['PnewM'](showInlineFeedback,_0x277b5a),updateQuestionNav();}function showInlineFeedback(_0x14d1ea){const _0x298f7d=_0x261c82,_0x570c3e={'ZmMBn':function(_0x42e10a){return _0x42e10a();},'qGJFk':function(_0x3bb4e4,_0x221da3){return _0x3bb4e4===_0x221da3;},'ebMta':'CYmoF','myvvZ':_0x298f7d(0x22d),'paHqz':_0x298f7d(0x208),'gJiWb':'timed_study','Ttdvz':_0x298f7d(0x45e),'kCrKs':_0x298f7d(0x2ed),'lOpPf':'answered'};if(currentMode!=='study'&&currentMode!==_0x570c3e[_0x298f7d(0x3b5)])return;const _0x2c72e1=document[_0x298f7d(0x37d)](_0x570c3e[_0x298f7d(0x1c1)]),_0x1087a8=_0x2c72e1[_0x298f7d(0x39c)](_0x570c3e[_0x298f7d(0x469)]),_0xc0f442=questionsData[currentQuestionIndex],_0x530e62=_0xc0f442['correct_choice_id'];let _0x270448=_0xc0f442['choices'][_0x298f7d(0x352)](_0x5f59b2=>_0x5f59b2['id']===_0x530e62);_0x2c72e1[_0x298f7d(0x235)][_0x298f7d(0x355)](_0x570c3e[_0x298f7d(0x3ef)]),_0x1087a8[_0x298f7d(0x465)]((_0x3383d4,_0x54a1e5)=>{const _0x5a0976=_0x298f7d,_0x565e69={'hNmSh':function(_0x180aaa){const _0x11b7df=_0x4c18;return _0x570c3e[_0x11b7df(0x44a)](_0x180aaa);}};if(_0x570c3e[_0x5a0976(0x41d)](_0x570c3e[_0x5a0976(0x271)],_0x570c3e[_0x5a0976(0x271)])){_0x3383d4['classList'][_0x5a0976(0x2c1)](_0x570c3e[_0x5a0976(0x353)]);if(_0x54a1e5===_0x270448)_0x3383d4[_0x5a0976(0x235)][_0x5a0976(0x355)](_0x570c3e['paHqz']);else{if(_0x570c3e[_0x5a0976(0x41d)](_0x54a1e5,selectedOption)&&!_0x14d1ea)_0x3383d4[_0x5a0976(0x235)][_0x5a0976(0x355)](_0x5a0976(0x3af));}}else _0x29ce84[_0x1669d9]['markedForReview']=!_0x9cb15[_0x41f78c][_0x5a0976(0x457)],_0x11a222(),_0x565e69[_0x5a0976(0x1da)](_0x1c2a5e);}),showSolution();}function showSolution(){const _0x4fcd08=_0x261c82,_0x21a084={'tRWQW':function(_0x56aab8){return _0x56aab8();},'jvZpW':function(_0x4b4d0b,_0x20f623){return _0x4b4d0b!==_0x20f623;},'kfrJF':_0x4fcd08(0x1fa),'rRFKg':function(_0x2154d8,_0x3da718){return _0x2154d8!==_0x3da718;},'fMuOH':_0x4fcd08(0x357),'scSDk':'No\x20solution\x20provided','GONoG':_0x4fcd08(0x3be),'aLYir':_0x4fcd08(0x336),'zGtSe':function(_0x5319ba,_0x36cdb3){return _0x5319ba!==_0x36cdb3;},'cFRnH':_0x4fcd08(0x308),'znFJz':_0x4fcd08(0x47f),'bFIDZ':'.m3u8','EDDzr':function(_0x1a75d9,_0x3dca72,_0x1e102d){return _0x1a75d9(_0x3dca72,_0x1e102d);},'iWjeN':'QrLTp','iWDNy':_0x4fcd08(0x3e2)};if(_0x21a084['jvZpW'](currentMode,_0x21a084[_0x4fcd08(0x2a5)])&&_0x21a084['rRFKg'](currentMode,_0x4fcd08(0x2e1)))return;const _0x2b6151=questionsData[currentQuestionIndex];document[_0x4fcd08(0x37d)](_0x21a084['fMuOH'])[_0x4fcd08(0x285)]=_0x2b6151[_0x4fcd08(0x2d0)]||_0x21a084[_0x4fcd08(0x2fc)];const _0x25a9bf=document[_0x4fcd08(0x37d)](_0x21a084[_0x4fcd08(0x1d3)]),_0x5191f1=document[_0x4fcd08(0x37d)](_0x21a084[_0x4fcd08(0x39f)]),_0x37804f=_0x2b6151[_0x4fcd08(0x41f)];if(_0x37804f){if(_0x21a084[_0x4fcd08(0x47d)](_0x21a084[_0x4fcd08(0x44e)],_0x21a084[_0x4fcd08(0x44e)]))_0x2322f4=_0x22b18f['filter'](_0x46d6e9=>!(_0x46d6e9[_0x4fcd08(0x3fe)][_0x4fcd08(0x263)](_0x1cb0c1[_0x4fcd08(0x2d9)]()['replace'](/ /g,'-'))&&_0x46d6e9[_0x4fcd08(0x345)]===_0x2ca4d9));else{_0x25a9bf[_0x4fcd08(0x235)]['remove'](_0x21a084[_0x4fcd08(0x1de)]);if(_0x37804f[_0x4fcd08(0x263)](_0x21a084[_0x4fcd08(0x3d7)]))_0x21a084[_0x4fcd08(0x488)](setupVideo,_0x5191f1,_0x37804f);else _0x5191f1[_0x4fcd08(0x2b2)]=_0x37804f;}}else _0x25a9bf[_0x4fcd08(0x235)][_0x4fcd08(0x355)](_0x21a084['znFJz']);const _0x367c94=document[_0x4fcd08(0x37d)](_0x4fcd08(0x1e6));_0x367c94[_0x4fcd08(0x285)]='';_0x2b6151['explanation_audio_eng']&&(_0x367c94[_0x4fcd08(0x285)]+=_0x4fcd08(0x3d1)+_0x2b6151['explanation_audio_eng']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');_0x2b6151['explanation_audio_hin']&&(_0x21a084['iWjeN']!==_0x4fcd08(0x36a)?_0x21a084[_0x4fcd08(0x34b)](_0x4b2142):_0x367c94['innerHTML']+=_0x4fcd08(0x315)+_0x2b6151[_0x4fcd08(0x461)]+_0x4fcd08(0x21e));const _0x5e6f3f=document[_0x4fcd08(0x37d)](_0x21a084[_0x4fcd08(0x289)]);_0x5e6f3f[_0x4fcd08(0x285)]='',_0x2b6151['explanation_images']&&_0x2b6151[_0x4fcd08(0x434)][_0x4fcd08(0x465)](_0x5e51b4=>{const _0xda4dbb=_0x4fcd08;if(_0x5e51b4)_0x5e6f3f[_0xda4dbb(0x285)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x5e51b4+_0xda4dbb(0x2c8);}),document[_0x4fcd08(0x37d)]('solutionContainer')[_0x4fcd08(0x235)][_0x4fcd08(0x2c1)](_0x4fcd08(0x47f));}function submitQuiz(){const _0xe9cfe7=_0x261c82,_0x61e53={'WHoDP':_0xe9cfe7(0x482),'YCEST':_0xe9cfe7(0x47f),'jAWnC':function(_0x510fab,_0x2f2ccc){return _0x510fab===_0x2f2ccc;},'icTHy':_0xe9cfe7(0x3da),'ROntb':_0xe9cfe7(0x436),'AWswo':'border-red-500','QPnrF':function(_0x249700,_0x33e7ce){return _0x249700+_0x33e7ce;},'WuvYt':function(_0x56d25c,_0x2d494d){return _0x56d25c!==_0x2d494d;},'NZkTd':function(_0xfd5c2,_0x359b31){return _0xfd5c2!==_0x359b31;},'jSxlC':_0xe9cfe7(0x478),'niKQd':function(_0x1eb40b,_0x36dd55){return _0x1eb40b(_0x36dd55);},'mWioO':_0xe9cfe7(0x327),'IkIiK':function(_0x2e14ae,_0x4d9bce){return _0x2e14ae-_0x4d9bce;},'LGQMS':'quizPerformanceData','oCuJb':function(_0x1f9996,_0x5035c5){return _0x1f9996-_0x5035c5;},'EHiAZ':function(_0x49f4be){return _0x49f4be();},'JhjiI':function(_0x577e26,_0x4a6269,_0x2ccd14,_0x11f580,_0x19b484){return _0x577e26(_0x4a6269,_0x2ccd14,_0x11f580,_0x19b484);}};if(timer)clearInterval(timer);if(!_0x61e53[_0xe9cfe7(0x3bb)](confirm,_0x61e53[_0xe9cfe7(0x27b)]))return;isQuizCompleted=!![];let _0x367845=0x0,_0x1e19a5=0x0;const _0x174fbb=_0x61e53[_0xe9cfe7(0x491)](Date[_0xe9cfe7(0x30d)](),quizStartTime);questionsData[_0xe9cfe7(0x465)]((_0x3708f0,_0x121c7b)=>{const _0x569b1a=_0xe9cfe7;if(_0x61e53[_0x569b1a(0x2bb)](_0x569b1a(0x363),_0x569b1a(0x475))){const _0xf2f977=questionStates[_0x121c7b];_0xf2f977[_0x569b1a(0x23a)]!==null&&(_0x61e53[_0x569b1a(0x2d3)](_0x3708f0[_0x569b1a(0x440)][_0xf2f977[_0x569b1a(0x23a)]]['id'],_0x3708f0['correct_choice_id'])?_0x61e53['NZkTd'](_0x61e53['jSxlC'],'XUNPi')?(_0x367845++,_0xf2f977['status']=_0x569b1a(0x208)):_0x301cc1[_0x569b1a(0x37d)](_0x61e53[_0x569b1a(0x3fb)])[_0x569b1a(0x235)][_0x569b1a(0x2c1)](_0x61e53[_0x569b1a(0x2c7)]):(_0x1e19a5++,_0xf2f977[_0x569b1a(0x27f)]=_0x569b1a(0x3af)));}else{const _0xbc590e=_0x61e53[_0x569b1a(0x2d3)](_0x79dff[_0x569b1a(0x23a)],_0x120d04),_0x19ed32=_0x61e53[_0x569b1a(0x2d3)](_0x473d9e['id'],_0x550b24);let _0x13b4ca=_0x61e53['icTHy'];if(_0x19ed32)_0x13b4ca=_0x61e53[_0x569b1a(0x240)];else{if(_0xbc590e)_0x13b4ca=_0x61e53[_0x569b1a(0x2e8)];}return _0x569b1a(0x27c)+_0x13b4ca+_0x569b1a(0x1df)+_0x5527ee[_0x569b1a(0x485)](_0x61e53[_0x569b1a(0x1cb)](0x41,_0x57279e))+_0x569b1a(0x2bc)+_0x5a5bd9[_0x569b1a(0x2e6)]+_0x569b1a(0x2db);}});const _0x2f7c4a=JSON[_0xe9cfe7(0x374)](localStorage[_0xe9cfe7(0x3bd)](_0x61e53[_0xe9cfe7(0x3c3)]))||[];_0x2f7c4a['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0xe9cfe7(0x30d)](),'totalTime':_0x174fbb,'stats':{'correct':_0x367845,'incorrect':_0x1e19a5,'notAttempted':_0x61e53['oCuJb'](questionsData[_0xe9cfe7(0x350)],_0x61e53[_0xe9cfe7(0x1cb)](_0x367845,_0x1e19a5))}}),localStorage[_0xe9cfe7(0x320)](_0x61e53[_0xe9cfe7(0x3c3)],JSON[_0xe9cfe7(0x1e4)](_0x2f7c4a)),stats[_0xe9cfe7(0x30c)]=_0x367845,stats['incorrectAnswers']=_0x1e19a5,_0x61e53[_0xe9cfe7(0x213)](markQuizAsCompleted),_0x61e53[_0xe9cfe7(0x1f1)](showPerformanceAnalysis,_0x367845,_0x1e19a5,_0x61e53[_0xe9cfe7(0x2c3)](questionsData[_0xe9cfe7(0x350)],_0x61e53[_0xe9cfe7(0x1cb)](_0x367845,_0x1e19a5)),_0x174fbb);}function showPerformanceAnalysis(_0xdba3c,_0x30f91a,_0x258bd3,_0x3626c4){const _0x2a3659=_0x261c82,_0x53f036={'EnMkj':function(_0x31b575,_0x327b9e){return _0x31b575>_0x327b9e;},'uuHHG':function(_0xf3e4a5,_0x248577){return _0xf3e4a5*_0x248577;},'wOyQO':function(_0xdb21a0,_0x18223b){return _0xdb21a0-_0x18223b;},'UZxQc':function(_0x58351b,_0x5e9281){return _0x58351b*_0x5e9281;},'OhYnV':function(_0x12be95,_0x31e36c){return _0x12be95/_0x31e36c;},'PcOvZ':_0x2a3659(0x32c),'LhAPn':'totalQuestionsResult','aFwmu':'correctResult','dlmcn':_0x2a3659(0x418),'izOMt':_0x2a3659(0x362),'fBEjx':function(_0x32d786,_0xee2ea7){return _0x32d786/_0xee2ea7;},'UIZxJ':function(_0x28f41e,_0x1198c2){return _0x28f41e%_0x1198c2;},'lqfUL':_0x2a3659(0x41c),'pwrrR':function(_0x392bc6,_0x2e7094){return _0x392bc6/_0x2e7094;},'SYLih':function(_0x4128f8,_0x2b02a4){return _0x4128f8/_0x2b02a4;},'Iuhfr':_0x2a3659(0x394),'DvZAe':_0x2a3659(0x47f)},_0x244bc1=document['getElementById'](_0x2a3659(0x47b)),_0x2af490=_0x53f036[_0x2a3659(0x205)](_0xdba3c+_0x30f91a,0x0)?Math['round'](_0xdba3c/(_0xdba3c+_0x30f91a)*0x64):0x0,_0x24cc55=_0x53f036['uuHHG'](_0x53f036[_0x2a3659(0x279)](0x2,Math['PI']),0x41),_0x3bd863=document['getElementById'](_0x2a3659(0x2a9));_0x3bd863[_0x2a3659(0x380)]['strokeDasharray']=_0x24cc55+'\x20'+_0x24cc55,_0x3bd863['style'][_0x2a3659(0x321)]=_0x53f036[_0x2a3659(0x305)](_0x24cc55,_0x53f036['UZxQc'](_0x53f036['OhYnV'](_0x2af490,0x64),_0x24cc55)),document['getElementById'](_0x53f036[_0x2a3659(0x1c4)])[_0x2a3659(0x2a8)]=_0x2af490+'%',document[_0x2a3659(0x37d)](_0x53f036[_0x2a3659(0x24b)])[_0x2a3659(0x2a8)]=questionsData[_0x2a3659(0x350)],document[_0x2a3659(0x37d)](_0x53f036['aFwmu'])[_0x2a3659(0x2a8)]=_0xdba3c,document[_0x2a3659(0x37d)](_0x53f036[_0x2a3659(0x1c3)])[_0x2a3659(0x2a8)]=_0x30f91a,document[_0x2a3659(0x37d)](_0x53f036[_0x2a3659(0x3cd)])[_0x2a3659(0x2a8)]=_0x258bd3;const _0x536793=Math['floor'](_0x53f036[_0x2a3659(0x267)](_0x3626c4,0xea60)),_0x9167d9=Math[_0x2a3659(0x451)](_0x53f036['fBEjx'](_0x53f036[_0x2a3659(0x3e1)](_0x3626c4,0xea60),0x3e8));document['getElementById'](_0x53f036[_0x2a3659(0x403)])[_0x2a3659(0x2a8)]=_0x536793+':'+_0x9167d9[_0x2a3659(0x265)]()[_0x2a3659(0x39a)](0x2,'0');const _0x29bc0b=_0x3626c4/questionsData[_0x2a3659(0x350)],_0x32cc9e=Math[_0x2a3659(0x451)](_0x53f036[_0x2a3659(0x2f5)](_0x29bc0b,0xea60)),_0x3159a3=Math['floor'](_0x53f036['SYLih'](_0x53f036[_0x2a3659(0x3e1)](_0x29bc0b,0xea60),0x3e8));document[_0x2a3659(0x37d)](_0x53f036['Iuhfr'])[_0x2a3659(0x2a8)]=_0x32cc9e+':'+_0x3159a3[_0x2a3659(0x265)]()['padStart'](0x2,'0'),_0x244bc1[_0x2a3659(0x235)][_0x2a3659(0x2c1)](_0x53f036['DvZAe']);}function closePerformanceModal(){const _0x516889=_0x261c82,_0x308e46={'IRSRV':_0x516889(0x47b)};document[_0x516889(0x37d)](_0x308e46[_0x516889(0x1fd)])[_0x516889(0x235)]['add']('hidden');}function reviewQuestions(){const _0x8850c1=_0x261c82,_0x5db699={'udWuw':_0x8850c1(0x26c),'UGsIb':function(_0x138333,_0x1b203c){return _0x138333/_0x1b203c;},'KZaBD':function(_0x37c830,_0xcca5e7){return _0x37c830%_0xcca5e7;},'gFBcc':_0x8850c1(0x3ac),'JZPRX':function(_0xd062c4,_0x3dee1e){return _0xd062c4===_0x3dee1e;},'amHVe':_0x8850c1(0x3da),'Ervto':_0x8850c1(0x436),'Otojg':function(_0x21f7eb,_0x333afc){return _0x21f7eb+_0x333afc;},'Lwcvv':_0x8850c1(0x20b),'rNdtm':_0x8850c1(0x3ca),'OFchy':function(_0x2b74d5,_0x566901){return _0x2b74d5!==_0x566901;},'JBqSU':_0x8850c1(0x317),'XoBta':function(_0x54588b,_0x2e343d){return _0x54588b===_0x2e343d;},'esYaf':function(_0x5ccc07,_0xf49fea){return _0x5ccc07===_0xf49fea;},'NgVPK':_0x8850c1(0x203),'njiOl':_0x8850c1(0x216),'TuXoY':_0x8850c1(0x208),'iShGI':_0x8850c1(0x3aa),'gqYvk':_0x8850c1(0x3af),'CsKkX':'div','nywNQ':function(_0x220abb,_0x4c3a4b){return _0x220abb===_0x4c3a4b;},'nFybk':_0x8850c1(0x3f7),'ebqPm':function(_0x464f17,_0x2596f2){return _0x464f17===_0x2596f2;},'hgGfo':_0x8850c1(0x3cf),'qmnit':_0x8850c1(0x39b),'USGaC':'hidden','afNzo':function(_0xa15c77){return _0xa15c77();}};document[_0x8850c1(0x37d)](_0x8850c1(0x38d))[_0x8850c1(0x235)]['remove'](_0x5db699[_0x8850c1(0x422)]);const _0x4af678=document['getElementById'](_0x8850c1(0x29f));_0x4af678[_0x8850c1(0x285)]='',questionsData['forEach']((_0x3fb21a,_0x3d6df2)=>{const _0x5c4932=_0x8850c1,_0x1bd267={'UyILG':function(_0x277530,_0x46fdbf){return _0x5db699['UGsIb'](_0x277530,_0x46fdbf);},'gJSCx':function(_0x142fbb,_0x2b8569){const _0x17776e=_0x4c18;return _0x5db699[_0x17776e(0x2b4)](_0x142fbb,_0x2b8569);},'EbRdy':_0x5db699[_0x5c4932(0x293)],'YpMpi':function(_0xe12f27,_0x25e1b9){return _0xe12f27+_0x25e1b9;},'gOErW':function(_0xf14212,_0x83dc56){return _0xf14212===_0x83dc56;},'CJxQk':function(_0x502a41,_0x35fcdd){const _0x528c58=_0x5c4932;return _0x5db699[_0x528c58(0x3f1)](_0x502a41,_0x35fcdd);},'lIjTy':_0x5db699['amHVe'],'cddyh':_0x5db699[_0x5c4932(0x2f1)],'FFpxF':function(_0x4d13c2,_0x107401){const _0x5292b2=_0x5c4932;return _0x5db699[_0x5292b2(0x25a)](_0x4d13c2,_0x107401);}},_0x51e87d=questionStates[_0x3d6df2],_0x278350=_0x3fb21a[_0x5c4932(0x288)];let _0x4b3fb2=_0x5db699[_0x5c4932(0x26e)],_0x14e78c=_0x5db699[_0x5c4932(0x2e7)];if(_0x5db699[_0x5c4932(0x1c6)](_0x51e87d[_0x5c4932(0x23a)],null)){if(_0x5db699[_0x5c4932(0x3f1)](_0x5db699[_0x5c4932(0x427)],_0x5c4932(0x36b))){const _0x47c69e=_0x18541e['floor'](_0x1bd267[_0x5c4932(0x36d)](_0x477667,0x3c)),_0x4383f6=_0x1bd267[_0x5c4932(0x246)](_0x1d87a3,0x3c);_0x818c5f['getElementById'](_0x1bd267[_0x5c4932(0x2a4)])['textContent']=_0x1bd267[_0x5c4932(0x463)](_0x1bd267[_0x5c4932(0x463)](_0x47c69e,':'),_0x4383f6[_0x5c4932(0x265)]()[_0x5c4932(0x39a)](0x2,'0'));}else{const _0x49afed=_0x3fb21a[_0x5c4932(0x440)][_0x51e87d[_0x5c4932(0x23a)]];_0x5db699[_0x5c4932(0x444)](_0x49afed['id'],_0x278350)?_0x5db699['esYaf'](_0x5db699[_0x5c4932(0x2e9)],_0x5db699[_0x5c4932(0x1cc)])?_0x5157f7[_0x5c4932(0x1c8)](_0x5db699[_0x5c4932(0x214)]):(_0x4b3fb2=_0x5db699[_0x5c4932(0x435)],_0x14e78c=_0x5db699[_0x5c4932(0x452)]):(_0x4b3fb2=_0x5db699[_0x5c4932(0x2e2)],_0x14e78c='Incorrect');}}const _0x14021c=document[_0x5c4932(0x33c)](_0x5db699[_0x5c4932(0x458)]);_0x14021c['className']='review-question\x20'+_0x4b3fb2;let _0x50b9ff=(_0x3fb21a['choices']||[])['map']((_0x3f9e8d,_0x492eab)=>{const _0x78c88d=_0x5c4932,_0xe0b1f0=_0x1bd267[_0x78c88d(0x233)](_0x51e87d[_0x78c88d(0x23a)],_0x492eab),_0x18e5fb=_0x1bd267[_0x78c88d(0x3dc)](_0x3f9e8d['id'],_0x278350);let _0x841868=_0x1bd267[_0x78c88d(0x412)];if(_0x18e5fb)_0x841868=_0x1bd267['cddyh'];else{if(_0xe0b1f0)_0x841868='border-red-500';}return _0x78c88d(0x27c)+_0x841868+_0x78c88d(0x1df)+String[_0x78c88d(0x485)](_0x1bd267[_0x78c88d(0x470)](0x41,_0x492eab))+_0x78c88d(0x2bc)+_0x3f9e8d[_0x78c88d(0x2e6)]+_0x78c88d(0x2db);})[_0x5c4932(0x273)]('');const _0x153c8c=_0x3fb21a[_0x5c4932(0x41f)]?_0x5c4932(0x36e)+_0x3d6df2+_0x5c4932(0x42f)+_0x3fb21a[_0x5c4932(0x41f)]+_0x5c4932(0x2ca):'';let _0x36aa9a='';if(_0x3fb21a[_0x5c4932(0x483)])_0x36aa9a+=_0x5c4932(0x3a1)+_0x3fb21a[_0x5c4932(0x483)]+_0x5c4932(0x21e);if(_0x3fb21a[_0x5c4932(0x461)])_0x36aa9a+=_0x5c4932(0x385)+_0x3fb21a[_0x5c4932(0x461)]+_0x5c4932(0x21e);let _0x1dbd4e=(_0x3fb21a[_0x5c4932(0x434)]||[])[_0x5c4932(0x43f)](_0xaf9db=>_0xaf9db?_0x5c4932(0x33e)+_0xaf9db+_0x5c4932(0x2c8):'')[_0x5c4932(0x273)]('');_0x14021c[_0x5c4932(0x285)]=_0x5c4932(0x343)+(_0x3d6df2+0x1)+_0x5c4932(0x437)+(_0x5db699[_0x5c4932(0x1eb)](_0x4b3fb2,_0x5c4932(0x208))?_0x5db699[_0x5c4932(0x281)]:_0x5db699[_0x5c4932(0x1e7)](_0x4b3fb2,_0x5db699['gqYvk'])?_0x5c4932(0x47c):_0x5db699[_0x5c4932(0x3ba)])+_0x5c4932(0x1f6)+_0x14e78c+_0x5c4932(0x2cd)+_0x3fb21a[_0x5c4932(0x2e6)]+_0x5c4932(0x347)+_0x50b9ff+_0x5c4932(0x3ce)+(_0x3fb21a[_0x5c4932(0x2d0)]||_0x5db699[_0x5c4932(0x1f5)])+_0x5c4932(0x411)+_0x153c8c+_0x5c4932(0x32e)+_0x36aa9a+_0x5c4932(0x32e)+_0x1dbd4e+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x4af678[_0x5c4932(0x2b6)](_0x14021c);}),_0x5db699[_0x8850c1(0x2af)](initializeReviewVideos);}function initializeReviewVideos(){const _0x2b87f3=_0x261c82,_0x559944={'YcCce':function(_0x5a6e67){return _0x5a6e67();},'vYHaO':_0x2b87f3(0x428),'Wfoaj':function(_0x573e29,_0x26522c){return _0x573e29!==_0x26522c;},'HeBYr':function(_0x152279,_0x1b9580){return _0x152279===_0x1b9580;},'oqSyw':'correct','ZmXLw':'incorrect','PmaJD':_0x2b87f3(0x1d8),'wuKqI':function(_0x30a991,_0x27a203,_0x484527){return _0x30a991(_0x27a203,_0x484527);},'JhLAJ':function(_0x16336e,_0x185ed9){return _0x16336e!==_0x185ed9;},'AkanU':_0x2b87f3(0x25e),'XEDmG':'wLDQR','julxa':_0x2b87f3(0x402)};document['querySelectorAll'](_0x559944[_0x2b87f3(0x332)])[_0x2b87f3(0x465)](_0x2ff976=>{const _0x5aa8d5=_0x2b87f3,_0x5ede93={'Hbypl':function(_0x53efd9){const _0x177175=_0x4c18;return _0x559944[_0x177175(0x3b4)](_0x53efd9);},'YIOJF':_0x559944[_0x5aa8d5(0x367)],'dUonq':function(_0x5b85e8,_0x47cce0){const _0x18ff6a=_0x5aa8d5;return _0x559944[_0x18ff6a(0x2bd)](_0x5b85e8,_0x47cce0);},'cBcPJ':function(_0x5de6fe,_0x282b28){const _0x37f83b=_0x5aa8d5;return _0x559944[_0x37f83b(0x312)](_0x5de6fe,_0x282b28);},'YxrNx':_0x559944[_0x5aa8d5(0x2a3)],'YGVFx':_0x559944[_0x5aa8d5(0x3d3)]},_0x3d8c62=_0x2ff976[_0x5aa8d5(0x2f6)][_0x5aa8d5(0x2b2)];if(_0x3d8c62&&_0x3d8c62[_0x5aa8d5(0x263)](_0x5aa8d5(0x1db))){if(_0x559944[_0x5aa8d5(0x312)](_0x559944[_0x5aa8d5(0x448)],'XTRjf')){if(!_0x157a45)_0x5ede93[_0x5aa8d5(0x274)](_0x2bc9e7);_0x5e70f5['location'][_0x5aa8d5(0x22b)]=_0x38ba50[_0x5aa8d5(0x29b)]||_0x5ede93[_0x5aa8d5(0x2f0)];}else _0x559944[_0x5aa8d5(0x359)](setupVideo,_0x2ff976,_0x3d8c62);}else{if(_0x3d8c62){if(_0x559944[_0x5aa8d5(0x301)](_0x559944['AkanU'],_0x559944[_0x5aa8d5(0x238)]))_0x2ff976[_0x5aa8d5(0x2b2)]=_0x3d8c62;else{const _0x308041=_0x3a3dda[_0x1d33b7];_0x5ede93[_0x5aa8d5(0x40c)](_0x308041[_0x5aa8d5(0x23a)],null)&&(_0x5ede93[_0x5aa8d5(0x28b)](_0x10dd9d[_0x5aa8d5(0x440)][_0x308041[_0x5aa8d5(0x23a)]]['id'],_0x3bfe3d[_0x5aa8d5(0x288)])?(_0x4ae9d4++,_0x308041[_0x5aa8d5(0x27f)]=_0x5ede93[_0x5aa8d5(0x2a2)]):(_0x4a1204++,_0x308041[_0x5aa8d5(0x27f)]=_0x5ede93[_0x5aa8d5(0x20d)]));}}}});}function retakeQuiz(){const _0xc6b3b8=_0x261c82,_0x3bdc6a={'tYYhu':function(_0x46ea15,_0x5c297d){return _0x46ea15(_0x5c297d);},'pMYSx':_0xc6b3b8(0x328),'qhZFu':'custom_quiz.html','kVMnW':_0xc6b3b8(0x26c),'pBGeD':function(_0x14739e){return _0x14739e();}};_0x3bdc6a['tYYhu'](confirm,_0x3bdc6a['pMYSx'])&&(window['location'][_0xc6b3b8(0x2b5)][_0xc6b3b8(0x40a)](_0x3bdc6a[_0xc6b3b8(0x29d)])&&localStorage[_0xc6b3b8(0x1c8)](_0x3bdc6a[_0xc6b3b8(0x43b)]),_0x3bdc6a[_0xc6b3b8(0x270)](clearProgress),location[_0xc6b3b8(0x221)]());}function loadBookmarkedQuestions(){const _0x53c2ef=_0x261c82,_0x37e89d={'EQBTc':function(_0x188db0,_0x3d0985){return _0x188db0(_0x3d0985);},'ZPtPS':_0x53c2ef(0x328),'fEsBO':_0x53c2ef(0x21d),'Syzrn':function(_0x205ed0){return _0x205ed0();},'GZvxw':function(_0x540c84,_0x333190){return _0x540c84!==_0x333190;},'aJzBm':'hONJb','gBveD':function(_0xb19ce5,_0x1d6c7c){return _0xb19ce5<_0x1d6c7c;},'HgYdu':'bookmarkedQuestions'},_0x2e52d1=JSON[_0x53c2ef(0x374)](localStorage[_0x53c2ef(0x3bd)](_0x37e89d[_0x53c2ef(0x476)]))||[];_0x2e52d1[_0x53c2ef(0x465)](_0x20d293=>{const _0x4e3dbd=_0x53c2ef;_0x20d293[_0x4e3dbd(0x3fe)][_0x4e3dbd(0x263)](quizName[_0x4e3dbd(0x2d9)]()[_0x4e3dbd(0x201)](/ /g,'-'))&&(_0x37e89d['GZvxw'](_0x4e3dbd(0x3f9),_0x37e89d[_0x4e3dbd(0x1ea)])?_0x37e89d[_0x4e3dbd(0x389)](_0x20d293[_0x4e3dbd(0x345)],questionsData['length'])&&(questionStates[_0x20d293[_0x4e3dbd(0x345)]][_0x4e3dbd(0x2b8)]=!![]):_0x37e89d[_0x4e3dbd(0x1fc)](_0x4555eb,_0x37e89d[_0x4e3dbd(0x1e5)])&&(_0xb383f9[_0x4e3dbd(0x361)][_0x4e3dbd(0x2b5)]['endsWith'](_0x37e89d[_0x4e3dbd(0x2ad)])&&_0x30779b[_0x4e3dbd(0x1c8)](_0x4e3dbd(0x26c)),_0x37e89d[_0x4e3dbd(0x36c)](_0x2225f4),_0x58bae0['reload']()));});}function toggleBookmark(){const _0x4a5729=_0x261c82,_0x1712bb={'evFsc':'bookmarkedQuestions','ePivp':function(_0x24cf88,_0x198eab){return _0x24cf88===_0x198eab;},'EFara':_0x4a5729(0x210),'vSnfk':function(_0x54c1ad){return _0x54c1ad();},'PzPbs':function(_0x322d8a){return _0x322d8a();}},_0x5fc556=!questionStates[currentQuestionIndex]['bookmarked'];questionStates[currentQuestionIndex][_0x4a5729(0x2b8)]=_0x5fc556;let _0x39d87f=JSON['parse'](localStorage['getItem'](_0x1712bb[_0x4a5729(0x2ee)]))||[];if(_0x5fc556){if(_0x1712bb[_0x4a5729(0x339)](_0x1712bb['EFara'],_0x1712bb[_0x4a5729(0x207)])){const _0x6e1722={'quizName':quizName,'quizFile':window['location'][_0x4a5729(0x2b5)]['split']('/')[_0x4a5729(0x200)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x4a5729(0x30d)]()};_0x39d87f[_0x4a5729(0x27e)](_0x6e1722);}else{const _0x3e7306=new _0x283bcf();_0x3e7306[_0x4a5729(0x291)](_0x125ab4),_0x3e7306[_0x4a5729(0x2ac)](_0x1d4563);}}else _0x39d87f=_0x39d87f[_0x4a5729(0x3ec)](_0x240297=>!(_0x240297[_0x4a5729(0x3fe)]['includes'](quizName[_0x4a5729(0x2d9)]()[_0x4a5729(0x201)](/ /g,'-'))&&_0x240297[_0x4a5729(0x345)]===currentQuestionIndex));localStorage[_0x4a5729(0x320)](_0x1712bb['evFsc'],JSON[_0x4a5729(0x1e4)](_0x39d87f)),_0x1712bb[_0x4a5729(0x47a)](updateBookmarkButton),_0x1712bb[_0x4a5729(0x400)](updateQuestionNav);}function updateBookmarkButton(){const _0x14b0de=_0x261c82,_0x12d64c={'KPgeL':_0x14b0de(0x38e),'JWUvU':_0x14b0de(0x3dd),'kzufS':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','JQYIt':_0x14b0de(0x28f)},_0x3ef4fb=document[_0x14b0de(0x37d)](_0x12d64c['KPgeL']),_0x2418cf=document['getElementById'](_0x14b0de(0x388)),_0x1758c0=questionStates[currentQuestionIndex][_0x14b0de(0x2b8)];_0x3ef4fb[_0x14b0de(0x417)]=_0x1758c0?_0x12d64c[_0x14b0de(0x33b)]:_0x12d64c[_0x14b0de(0x2a7)],_0x2418cf[_0x14b0de(0x2a8)]=_0x1758c0?_0x14b0de(0x38f):_0x12d64c[_0x14b0de(0x333)];}function toggleMarkForReview(){const _0x3f5b50=_0x261c82,_0x376d80={'bCdfA':function(_0x42e8f9){return _0x42e8f9();}};questionStates[currentQuestionIndex][_0x3f5b50(0x457)]=!questionStates[currentQuestionIndex]['markedForReview'],_0x376d80[_0x3f5b50(0x2ea)](updateMarkReviewButton),_0x376d80[_0x3f5b50(0x2ea)](updateQuestionNav);}function updateMarkReviewButton(){const _0xc99c30=_0x261c82,_0x2c8186={'DfuUH':_0xc99c30(0x40f),'MOnyg':_0xc99c30(0x429),'WEXWh':_0xc99c30(0x48a),'fSlSK':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center'},_0x60df35=document[_0xc99c30(0x37d)](_0x2c8186['DfuUH']),_0x5c0c32=document[_0xc99c30(0x37d)](_0x2c8186[_0xc99c30(0x30e)]),_0x9246b4=questionStates[currentQuestionIndex][_0xc99c30(0x457)];_0x60df35['className']=_0x9246b4?_0x2c8186[_0xc99c30(0x24f)]:_0x2c8186[_0xc99c30(0x42d)],_0x5c0c32[_0xc99c30(0x2a8)]=_0x9246b4?_0xc99c30(0x390):_0xc99c30(0x22e);}function previousQuestion(){const _0x162bfc=_0x261c82,_0x65cd1d={'MhfvK':_0x162bfc(0x40f),'pbyar':'markReviewText','gzagA':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','QgiIF':_0x162bfc(0x390),'wmFPF':function(_0x19241a,_0x4a11c9){return _0x19241a>_0x4a11c9;},'aVBRT':function(_0x1fead9,_0x4f894c){return _0x1fead9!==_0x4f894c;},'kgbaK':_0x162bfc(0x32a),'BZyEZ':function(_0x2d6dfc){return _0x2d6dfc();}};if(_0x65cd1d[_0x162bfc(0x462)](currentQuestionIndex,0x0)){if(_0x65cd1d[_0x162bfc(0x37b)](_0x65cd1d[_0x162bfc(0x376)],_0x65cd1d['kgbaK'])){const _0x4d3aec=_0x161479['getElementById'](_0x65cd1d[_0x162bfc(0x381)]),_0x1b463f=_0x397b95[_0x162bfc(0x37d)](_0x65cd1d[_0x162bfc(0x3a3)]),_0x4bd5a6=_0x16e84a[_0x258622][_0x162bfc(0x457)];_0x4d3aec[_0x162bfc(0x417)]=_0x4bd5a6?_0x162bfc(0x48a):_0x65cd1d['gzagA'],_0x1b463f[_0x162bfc(0x2a8)]=_0x4bd5a6?_0x65cd1d[_0x162bfc(0x275)]:_0x162bfc(0x22e);}else questionStartTime&&(questionStates[currentQuestionIndex][_0x162bfc(0x416)]+=Date['now']()-questionStartTime),currentQuestionIndex--,_0x65cd1d[_0x162bfc(0x370)](displayQuestion),_0x65cd1d[_0x162bfc(0x370)](saveProgress);}}function nextQuestion(){const _0x14919c=_0x261c82,_0x41ad2d={'WzoGT':'.m3u8','BEWDd':function(_0xf5224e,_0x570de3,_0x3ab4be){return _0xf5224e(_0x570de3,_0x3ab4be);},'HBSZM':function(_0x3e0cb2,_0x2e2231){return _0x3e0cb2-_0x2e2231;},'BWWtq':function(_0x24005e){return _0x24005e();},'bTvrn':function(_0x362cbb){return _0x362cbb();},'aISJp':function(_0x518de3,_0x508d24){return _0x518de3===_0x508d24;},'dzMsD':function(_0x191c6d,_0x5d2e2d){return _0x191c6d-_0x5d2e2d;},'aJUWp':function(_0x26ad1a,_0x4b9cc2){return _0x26ad1a===_0x4b9cc2;},'XwSJz':_0x14919c(0x1ed),'RMwAL':_0x14919c(0x3c1),'mGGhw':function(_0x5e12a0,_0x18657a){return _0x5e12a0===_0x18657a;},'SemsP':_0x14919c(0x1ec),'orZXU':function(_0x41801a,_0x33e6a6){return _0x41801a(_0x33e6a6);},'wVNVC':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','aWGnM':_0x14919c(0x3a4),'GsJpV':function(_0x2d3cf0,_0x4b6cbb){return _0x2d3cf0!==_0x4b6cbb;},'uaJKM':_0x14919c(0x499),'eVNuS':function(_0x2806ab){return _0x2806ab();}};if(questionStartTime){if(_0x41ad2d[_0x14919c(0x3de)]('hrkNb',_0x14919c(0x38c))){const _0x599a5f=_0x311575?function(){if(_0x5c1dee){const _0xb567fd=_0xfe3274['apply'](_0x5b791e,arguments);return _0x32fe4d=null,_0xb567fd;}}:function(){};return _0xcee8f8=![],_0x599a5f;}else questionStates[currentQuestionIndex][_0x14919c(0x416)]+=_0x41ad2d[_0x14919c(0x3c0)](Date[_0x14919c(0x30d)](),questionStartTime);}if(currentQuestionIndex<_0x41ad2d[_0x14919c(0x24c)](questionsData[_0x14919c(0x350)],0x1))currentQuestionIndex++,_0x41ad2d[_0x14919c(0x44d)](displayQuestion),saveProgress();else{if(_0x41ad2d[_0x14919c(0x258)](_0x41ad2d[_0x14919c(0x269)],_0x41ad2d[_0x14919c(0x269)])){if(_0x41ad2d[_0x14919c(0x3de)](currentMode,_0x41ad2d['RMwAL'])||_0x41ad2d[_0x14919c(0x43e)](currentMode,_0x41ad2d[_0x14919c(0x334)]))_0x41ad2d[_0x14919c(0x1ee)](confirm,_0x41ad2d['wVNVC'])&&_0x41ad2d[_0x14919c(0x44d)](submitQuiz);else{if(_0x41ad2d[_0x14919c(0x1ee)](confirm,_0x41ad2d[_0x14919c(0x455)])){if(_0x41ad2d[_0x14919c(0x3bf)](_0x41ad2d[_0x14919c(0x3f4)],_0x41ad2d[_0x14919c(0x3f4)])){const _0x4765a6=_0x464974[_0x14919c(0x2f6)]['src'];if(_0x4765a6&&_0x4765a6['includes'](_0x41ad2d[_0x14919c(0x259)]))_0x41ad2d[_0x14919c(0x20c)](_0x1bde97,_0x2d5677,_0x4765a6);else _0x4765a6&&(_0x5a221c[_0x14919c(0x2b2)]=_0x4765a6);}else currentQuestionIndex=0x0,_0x41ad2d[_0x14919c(0x2d5)](displayQuestion),saveProgress();}}}else _0x8f51ed&&(_0x436eae[_0x26d1bb]['timeSpent']+=_0x41ad2d[_0x14919c(0x3c0)](_0x4639f3[_0x14919c(0x30d)](),_0x27a3a9)),_0x12e10b--,_0x41ad2d[_0x14919c(0x45d)](_0xe48e1a),_0x41ad2d[_0x14919c(0x44d)](_0x9d3fe8);}}function startTimer(){const _0x1087cc=_0x261c82,_0x4aba5a={'WFoTh':function(_0x71ddd2,_0x56e786){return _0x71ddd2===_0x56e786;},'BmFTr':function(_0x119e7e){return _0x119e7e();},'xSaSQ':function(_0x50adf5,_0x5ddbb8){return _0x50adf5<=_0x5ddbb8;},'KfOvR':function(_0x2befda,_0x48c077){return _0x2befda!==_0x48c077;},'tUVHV':_0x1087cc(0x28e),'MBwmz':function(_0xf6f256,_0x5bf40e){return _0xf6f256(_0x5bf40e);},'PqghZ':_0x1087cc(0x1ec),'XXkcs':function(_0x3a1ce3,_0x59b0c3){return _0x3a1ce3!==_0x59b0c3;},'JSHlK':function(_0x5ee673,_0x302651,_0x52151b){return _0x5ee673(_0x302651,_0x52151b);}};if(timer)clearInterval(timer);timeRemaining=0x78,updateTimerDisplay(),timer=_0x4aba5a[_0x1087cc(0x1ef)](setInterval,()=>{const _0x5306fc=_0x1087cc,_0x55f9b2={'fUcLG':function(_0x291f35,_0x5b4ed8){const _0x441f5e=_0x4c18;return _0x4aba5a[_0x441f5e(0x369)](_0x291f35,_0x5b4ed8);},'Ydyap':function(_0xf1a1eb){const _0xbd343d=_0x4c18;return _0x4aba5a[_0xbd343d(0x472)](_0xf1a1eb);}};timeRemaining--,_0x4aba5a[_0x5306fc(0x472)](updateTimerDisplay);if(_0x4aba5a[_0x5306fc(0x34f)](timeRemaining,0x0)){if(_0x4aba5a[_0x5306fc(0x45b)](_0x4aba5a[_0x5306fc(0x206)],_0x4aba5a[_0x5306fc(0x206)]))_0x397c5e(_0x15e489),_0x55f9b2[_0x5306fc(0x450)](_0x418f00,_0x5306fc(0x1ec))?_0x55f9b2[_0x5306fc(0x2d4)](_0x27fb74):_0x55f9b2[_0x5306fc(0x2d4)](_0x3b12a9);else{_0x4aba5a['MBwmz'](clearInterval,timer);if(_0x4aba5a[_0x5306fc(0x369)](currentMode,_0x4aba5a[_0x5306fc(0x2dd)])){if(_0x4aba5a[_0x5306fc(0x497)]('yTKGr',_0x5306fc(0x48d))){const _0x5a8299=_0x347815[_0x5306fc(0x449)][_0x5306fc(0x46f)][_0x5306fc(0x39d)](_0x2f27f0),_0xb5bca0=_0x1e0ec4[_0x59d1a8],_0x5a8cec=_0x5a0ef2[_0xb5bca0]||_0x5a8299;_0x5a8299[_0x5306fc(0x2f2)]=_0x5d9baa[_0x5306fc(0x39d)](_0x5ab26f),_0x5a8299[_0x5306fc(0x265)]=_0x5a8cec[_0x5306fc(0x265)]['bind'](_0x5a8cec),_0x2cda51[_0xb5bca0]=_0x5a8299;}else _0x4aba5a['BmFTr'](submitQuiz);}else nextQuestion();}}},0x3e8);}function updateTimerDisplay(){const _0x370107=_0x261c82,_0x521cc0={'hjHkZ':function(_0x555fc2,_0x3d376d){return _0x555fc2/_0x3d376d;},'qVsQR':_0x370107(0x3ac),'NMAgp':function(_0x2ebae3,_0x3d1ff7){return _0x2ebae3+_0x3d1ff7;},'ioIGf':function(_0x1f50d7,_0x1a2763){return _0x1f50d7+_0x1a2763;}},_0x39d898=Math[_0x370107(0x451)](_0x521cc0[_0x370107(0x39e)](timeRemaining,0x3c)),_0x55ab08=timeRemaining%0x3c;document[_0x370107(0x37d)](_0x521cc0['qVsQR'])['textContent']=_0x521cc0[_0x370107(0x46b)](_0x521cc0[_0x370107(0x2c2)](_0x39d898,':'),_0x55ab08[_0x370107(0x265)]()[_0x370107(0x39a)](0x2,'0'));}function toggleSidebar(){const _0x225ad1=_0x261c82,_0x39a2f6={'NxHhG':'quizSidebar','FvFQT':_0x225ad1(0x45a)};document[_0x225ad1(0x37d)](_0x39a2f6[_0x225ad1(0x307)])[_0x225ad1(0x235)][_0x225ad1(0x486)](_0x39a2f6[_0x225ad1(0x21c)]);}document[_0x261c82(0x3f3)](_0x261c82(0x1e1),()=>{const _0x15177d=_0x261c82,_0x3ddc51={'yadFH':function(_0x2ce938,_0x3ab9e1){return _0x2ce938+_0x3ab9e1;},'mjBZZ':_0x15177d(0x473),'uUWum':_0x15177d(0x286),'lGGzk':'quizHierarchy','mzUGw':'\x20>\x20','dzCuM':_0x15177d(0x208),'bmhvM':'(((.+)+)+)+$','zqKyu':function(_0x2eefb7){return _0x2eefb7();},'aYxZO':function(_0x3be8e1,_0x3e0771){return _0x3be8e1!==_0x3e0771;},'wYURo':'rfORV','KJrAF':'modeModal','EYzXL':_0x15177d(0x421),'ykCdh':_0x15177d(0x35c),'ttyOD':function(_0x58cf9f){return _0x58cf9f();},'wyhaw':function(_0x3edcad,_0x1af8b4){return _0x3edcad!==_0x1af8b4;},'VuFbd':_0x15177d(0x393),'pscLi':_0x15177d(0x35e)};if(resume)_0x3ddc51['zqKyu'](loadProgress)?_0x3ddc51[_0x15177d(0x492)](_0x3ddc51[_0x15177d(0x2be)],_0x15177d(0x2a1))?(_0x189754=_0x4f1601[_0x15177d(0x48c)],_0x534768=_0x1f3d8f[_0x15177d(0x1f9)],_0x457b72=_0x269855[_0x15177d(0x3f6)],_0x57aebc[_0x15177d(0x468)]=_0x3ddc51[_0x15177d(0x337)](_0x40896e,_0x3ddc51[_0x15177d(0x375)]),_0xc7e2d1[_0x15177d(0x37d)](_0x3ddc51[_0x15177d(0x45f)])['textContent']=_0x491b9f['length'],_0x584dd1[_0x15177d(0x37d)](_0x3ddc51[_0x15177d(0x46d)])[_0x15177d(0x2a8)]=_0x4f10b6[_0x15177d(0x273)](_0x3ddc51[_0x15177d(0x260)])):(document['getElementById'](_0x3ddc51['KJrAF'])['style'][_0x15177d(0x2df)]=_0x15177d(0x27a),_0x3ddc51[_0x15177d(0x26a)](initializeQuiz)):(_0x3ddc51['zqKyu'](clearProgress),document['getElementById'](_0x3ddc51[_0x15177d(0x1cd)])[_0x15177d(0x380)][_0x15177d(0x2df)]=_0x3ddc51[_0x15177d(0x410)]);else{if(!window[_0x15177d(0x361)]['pathname'][_0x15177d(0x40a)](_0x15177d(0x21d)))_0x3ddc51['aYxZO'](_0x3ddc51[_0x15177d(0x2ec)],_0x3ddc51[_0x15177d(0x2ec)])?(_0x2bc2ab++,_0x24e79e[_0x15177d(0x27f)]=_0x3ddc51[_0x15177d(0x283)]):(_0x3ddc51['ttyOD'](clearProgress),document['getElementById'](_0x3ddc51['KJrAF'])[_0x15177d(0x380)][_0x15177d(0x2df)]=_0x15177d(0x421));else{if(_0x3ddc51[_0x15177d(0x2c0)](_0x3ddc51['VuFbd'],_0x3ddc51[_0x15177d(0x219)]))initializeQuiz();else return _0x5b8b7f['toString']()['search'](KdBiMi[_0x15177d(0x490)])[_0x15177d(0x265)]()[_0x15177d(0x449)](_0x540c1e)[_0x15177d(0x290)]('(((.+)+)+)+$');}}}),document[_0x261c82(0x3f3)](_0x261c82(0x426),function(_0xaedec6){const _0x59b1b8=_0x261c82,_0x317a9c={'YLAVB':function(_0x144c89,_0x1731c1,_0x555694){return _0x144c89(_0x1731c1,_0x555694);},'NOObJ':'video[data-src]','vUJsD':function(_0x363763){return _0x363763();},'SMvkn':function(_0x417b69,_0x279c96){return _0x417b69!==_0x279c96;},'laQwV':'none','IEVuD':function(_0x49fc37,_0x884cbe){return _0x49fc37===_0x884cbe;},'Xlwgk':_0x59b1b8(0x47b),'qMqYa':function(_0x136832,_0x375f1){return _0x136832>=_0x375f1;},'AYAKT':function(_0x110b2b,_0x1b77f1){return _0x110b2b<=_0x1b77f1;},'qKxSK':function(_0x12ee47,_0x136cff){return _0x12ee47-_0x136cff;},'oLzLy':function(_0x446fa7,_0x26813f){return _0x446fa7(_0x26813f);},'MamLS':_0x59b1b8(0x2ed),'URMjB':function(_0x930805,_0x187a83){return _0x930805(_0x187a83);},'Lopud':function(_0x43310c,_0xb4ae9c){return _0x43310c===_0xb4ae9c;},'xQfxP':_0x59b1b8(0x3d4),'GOJPv':_0x59b1b8(0x1f0),'VjiEN':_0x59b1b8(0x2b3),'Sdtoj':function(_0x546a17){return _0x546a17();},'wSPZZ':function(_0x19e58e,_0x4d88ff){return _0x19e58e===_0x4d88ff;},'UOYHQ':'ArrowRight','PLTfh':function(_0x19b8e9){return _0x19b8e9();},'UqTwL':function(_0xd0c407,_0x10c58b){return _0xd0c407===_0x10c58b;},'QKqCQ':_0x59b1b8(0x1fa),'bnOic':function(_0x774450,_0x507f98){return _0x774450===_0x507f98;},'tVLMF':'timed_study','BQZQw':function(_0x5ce8aa,_0x2d79c8){return _0x5ce8aa===_0x2d79c8;},'JRFbB':_0x59b1b8(0x30f),'qTZoJ':'test','TjJqv':_0x59b1b8(0x1ec),'guZjn':function(_0x44e448,_0xef7f90){return _0x44e448===_0xef7f90;},'WXimJ':function(_0x3460c0,_0x1e0694){return _0x3460c0===_0x1e0694;}};if(_0x317a9c[_0x59b1b8(0x454)](document[_0x59b1b8(0x37d)](_0x59b1b8(0x364))[_0x59b1b8(0x380)][_0x59b1b8(0x2df)],_0x317a9c[_0x59b1b8(0x1c0)]))return;if(_0x317a9c['IEVuD'](document[_0x59b1b8(0x37d)](_0x317a9c[_0x59b1b8(0x231)])[_0x59b1b8(0x235)]['contains'](_0x59b1b8(0x47f)),![]))return;if(_0x317a9c['qMqYa'](_0xaedec6[_0x59b1b8(0x28d)],'1')&&_0x317a9c[_0x59b1b8(0x247)](_0xaedec6[_0x59b1b8(0x28d)],'4')){if(_0x317a9c[_0x59b1b8(0x454)](_0x59b1b8(0x471),_0x59b1b8(0x44c))){const _0x4a6d07=_0x317a9c[_0x59b1b8(0x249)](_0x317a9c[_0x59b1b8(0x314)](parseInt,_0xaedec6[_0x59b1b8(0x28d)]),0x1),_0x121af2=document[_0x59b1b8(0x39c)](_0x317a9c['MamLS']);if(_0x4a6d07<_0x121af2[_0x59b1b8(0x350)])_0x317a9c[_0x59b1b8(0x248)](selectOption,_0x4a6d07);}else{const _0x21a9df={'LMmgk':function(_0x55c8fd,_0x1292a8,_0x340fff){const _0x3155ab=_0x59b1b8;return _0x317a9c[_0x3155ab(0x3c4)](_0x55c8fd,_0x1292a8,_0x340fff);}};_0x4a8ccd[_0x59b1b8(0x39c)](_0x317a9c[_0x59b1b8(0x3ed)])['forEach'](_0x3e8e4a=>{const _0x56d521=_0x59b1b8,_0xb3a5cd=_0x3e8e4a['dataset']['src'];if(_0xb3a5cd&&_0xb3a5cd[_0x56d521(0x263)](_0x56d521(0x1db)))_0x21a9df[_0x56d521(0x3c6)](_0x4370f2,_0x3e8e4a,_0xb3a5cd);else _0xb3a5cd&&(_0x3e8e4a[_0x56d521(0x2b2)]=_0xb3a5cd);});}}else{if(_0x317a9c[_0x59b1b8(0x360)](_0xaedec6['key'],_0x317a9c[_0x59b1b8(0x287)]))_0x317a9c['GOJPv']===_0x317a9c['VjiEN']?_0x436ca6=_0x145685:_0x317a9c[_0x59b1b8(0x2cc)](previousQuestion);else{if(_0x317a9c[_0x59b1b8(0x338)](_0xaedec6[_0x59b1b8(0x28d)],_0x317a9c[_0x59b1b8(0x2c9)])||_0x317a9c[_0x59b1b8(0x360)](_0xaedec6[_0x59b1b8(0x28d)],'\x20'))_0x317a9c[_0x59b1b8(0x360)](_0x59b1b8(0x22a),'cRHaJ')?(_0xaedec6['preventDefault'](),_0x317a9c[_0x59b1b8(0x44f)](nextQuestion)):_0x37c5ba[_0x59b1b8(0x285)]+=_0x59b1b8(0x315)+_0x2452cc[_0x59b1b8(0x461)]+_0x59b1b8(0x21e);else{if(_0xaedec6['key'][_0x59b1b8(0x2d9)]()==='b'&&(_0x317a9c['UqTwL'](currentMode,_0x317a9c[_0x59b1b8(0x340)])||_0x317a9c[_0x59b1b8(0x443)](currentMode,_0x317a9c['tVLMF'])))_0x317a9c[_0x59b1b8(0x42a)](_0x59b1b8(0x484),_0x317a9c[_0x59b1b8(0x498)])?_0x317a9c['vUJsD'](_0x5baa3c):_0x317a9c[_0x59b1b8(0x299)](toggleBookmark);else{if(_0xaedec6['key'][_0x59b1b8(0x2d9)]()==='m'&&(_0x317a9c['UqTwL'](currentMode,_0x317a9c[_0x59b1b8(0x28a)])||_0x317a9c['UqTwL'](currentMode,_0x317a9c[_0x59b1b8(0x3a9)])))toggleMarkForReview();else _0xaedec6['key']['toLowerCase']()==='s'&&(_0x317a9c[_0x59b1b8(0x22c)](currentMode,_0x317a9c['qTZoJ'])||_0x317a9c[_0x59b1b8(0x368)](currentMode,'timed_exam'))&&submitQuiz();}}}}});</script>

</body></html>